<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">BMC Prim Care</journal-id><journal-id journal-id-type="iso-abbrev">BMC Prim Care</journal-id><journal-id journal-id-type="pmc-domain-id">4148</journal-id><journal-id journal-id-type="pmc-domain">bmcpp</journal-id><journal-title-group><journal-title>BMC Primary Care</journal-title></journal-title-group><issn pub-type="epub">2731-4553</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11656854</article-id><article-id pub-id-type="pmcid-ver">PMC11656854.1</article-id><article-id pub-id-type="pmcaid">11656854</article-id><article-id pub-id-type="pmcaiid">11656854</article-id><article-id pub-id-type="pmid">39702052</article-id><article-id pub-id-type="doi">10.1186/s12875-024-02636-6</article-id><article-id pub-id-type="publisher-id">2636</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Patient-oriented unsupervised learning to uncover the patterns of multimorbidity associated with stroke using primary care electronic health records</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Delord</surname><given-names initials="M">Marc</given-names></name><address><email>marc.delord@kcl.ac.uk</email></address><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Sun</surname><given-names initials="X">Xiaohui</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Learoyd</surname><given-names initials="A">Annastazia</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Curcin</surname><given-names initials="V">Vasa</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wolfe</surname><given-names initials="C">Charles</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ashworth</surname><given-names initials="M">Mark</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Douiri</surname><given-names initials="A">Abdel</given-names></name><xref ref-type="aff" rid="Aff1"/></contrib><aff id="Aff1"><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0220mzb33</institution-id><institution-id institution-id-type="GRID">grid.13097.3c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2322 6764</institution-id><institution>School of Life Course &amp; Population Sciences, Department of Population Health Sciences, King&#8217;s College London, </institution></institution-wrap>London, UK </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="collection"><year>2024</year></pub-date><volume>25</volume><issue-id pub-id-type="pmc-issue-id">452033</issue-id><elocation-id>419</elocation-id><history><date date-type="received"><day>10</day><month>4</month><year>2024</year></date><date date-type="accepted"><day>22</day><month>10</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>19</day><month>12</month><year>2024</year></date></event><event event-type="pmc-live"><date><day>19</day><month>12</month><year>2024</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-12-20 12:25:25.727"><day>20</day><month>12</month><year>2024</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="12875_2024_Article_2636.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par1">We aimed to identify and characterise the longitudinal patterns of multimorbidity associated with stroke.</p></sec><sec><title>Methods</title><p id="Par2">We used an unsupervised patient-oriented clustering approach to analyse primary care electronic health records (EHR) of 30 common long-term conditions (LTC) in patients with stroke aged over 18, registered in 41 general practices in south London between 2005 and 2021.</p></sec><sec><title>Results</title><p id="Par3">Of 849,968 registered patients, 9,847 (1.16%) had a record of stroke and 46.5% were female. The median age at record of stroke was 65.0 year (IQR: 51.5-77.0) and the median number of LTCs in addition to stroke was 3 (IQR: 2-5). We identified eight clusters of multimorbidity with contrasted socio-demographic characteristics (age, gender, and ethnicity) and risk factors. Beside a core of 3 clusters associated with conventional stroke risk-factors, minor clusters exhibited less common combinations of LTCs including mental health conditions, asthma, osteoarthritis and sickle cell anaemia. Importantly, complex profiles combining mental health conditions, infectious diseases and substance dependency emerged.</p></sec><sec><title>Conclusion</title><p id="Par4">This novel longitudinal and patient-oriented perspective on multimorbidity addresses existing gaps in mapping the patterns of stroke-associated multimorbidity not only in terms of LTCs, but also socio-demographic characteristics, and suggests potential for more efficient and patient-oriented healthcare models.</p></sec><sec><title>Supplementary Information</title><p>The online version contains supplementary material available at 10.1186/s12875-024-02636-6.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Multimorbidity</kwd><kwd>Stroke</kwd><kwd>Unsupervised learning</kwd><kwd>Electronic health records</kwd><kwd>Primary health care</kwd><kwd>Life course epidemiology</kwd></kwd-group><funding-group><award-group><funding-source><institution>Guy's and St Thomas' NHS Foundation Trust,United Kingdom</institution></funding-source><award-id>EIC180702</award-id></award-group></funding-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100000272</institution-id><institution>National Institute for Health and Care Research</institution></institution-wrap></funding-source><award-id>NIHR202339</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2024</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par11">Despite recent attention to the topic, current knowledge on multimorbidity in stroke remains limited [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR4">4</xref>]. Multimorbidity is commonly defined as the co-occurrence of two or more long-term conditions (LTCs) [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR6">6</xref>]. In the context of the rising prevalence of LTCs within an ageing population [<xref ref-type="bibr" rid="CR7">7</xref>], most patients with stroke present at least one or more additional LTC [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. These factors challenge primary healthcare services, as multimorbidity increases patients complexity which may result in poorer short- and long-term outcome after stroke [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>] and increased costs of care [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR6">6</xref>, <xref ref-type="bibr" rid="CR9">9</xref>].</p><p id="Par12">To date, the analysis of stroke related multimorbidity has been based on classical epidemiological approaches such as case-control studies, focusing on the association of potential stroke risk factors with stroke status [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] or cross-sectional studies assessing the impact of different indices of multimorbidity, such as the Charlson Comorbidity Index scores [<xref ref-type="bibr" rid="CR8">8</xref>] or the simple count of LTCs on stroke outcomes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR12">12</xref>].</p><p id="Par13">These approaches, however, remain non-specific, and beyond the necessary characterisation of risk factors and long-term conditions associated with stroke [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR8">8</xref>], the need arise for a better understanding of multimorbidity associated with stroke. This includes patients stratification according to the main patterns of multimorbidity, the longitudinal description of defined clusters, including their relative size, associated socio-demographic characteristics and risk factors [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par14">Other methods used in the general setting to analyse trajectories of multimorbidity relies on two main approaches [<xref ref-type="bibr" rid="CR14">14</xref>]. The first involves the count of long-term conditions at regular intervals over time. This often includes creating composite scores or indices that reflect the accumulation of multiple long-term conditions in patients. This approach typically involves advanced statistical techniques such as multilevel modelling and growth curve analysis. The second approach focuses on modelling transitions between a necessary limited number of long-term conditions.</p><p id="Par15">The life course setting represents an alternative framework to meet this objective [<xref ref-type="bibr" rid="CR15">15</xref>] using primary care electronic health records (EHRs) and unsupervised learning methods [<xref ref-type="bibr" rid="CR16">16</xref>]. Unlike clustering approaches used in cross-sectional studies [<xref ref-type="bibr" rid="CR17">17</xref>] which result in non-specific descriptions of recurrent LTCs observed in analysed cohorts, or longitudinal non specific methods based on indices these approaches allow to use longitudinal EHRs to define individual patient health trajectories using all available patient health history [<xref ref-type="bibr" rid="CR18">18</xref>]. Resulting patient individual health trajectories are further analysed as input in an unsupervised clustering procedure to identify sub-populations of patients (clusters) characterised by distinct life course health trajectories. In turn, the longitudinal description of the main trajectories in terms of patterns of multimorbidity allows a better understanding of patients experience and complexity and addresses evidence-gaps toward patient-oriented approaches of care delivery [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p><p id="Par16">In this study, we analysed longitudinal primary care EHRs related to up to 30 LTCs, including stroke, and conventional stroke risk factors such as hypertension and diabetes, in 9,847 patients with stoke using a patient-oriented unsupervised learning approach. Our objective was to identify and characterise the main patterns of multimorbidity associated with stroke.</p></sec><sec id="Sec2"><title>Patients and method</title><sec id="Sec3"><title>Primary care data</title><p id="Par17">We utilised EHRs of 30 LTCs in adult patients aged over 18 and registered in 41 general practices in south London between April 2005 and April 2021. EHRs consisted of anonymized, patient-level data from routinely collected &#8217;real-world&#8217; records, encoded using Read codes and SNOMED Clinical Terms (CT), and managed within the Egton Medical Information Systems (EMIS). This dataset included the dates of diagnosis for selected LTCs, coded according to the Quality and Outcomes Framework (QOF), based on QOF38 definitions. The anonymized, preprocessed EHR data was provided by Lambeth Datanet following project approval by the Lambeth Clinical Commissioning Group.</p><p id="Par18">LTCs where selected as per the consensus definition for multimorbidity of the Academy of Medical Sciences [<xref ref-type="bibr" rid="CR4">4</xref>] and a definition of multimorbidity proposed by Hafezparast et al. [<xref ref-type="bibr" rid="CR20">20</xref>] which aimed to define multimorbidity for urban, multi-ethnic, deprived and young age communities. Accordingly, selected LTCs refer to either physical non-communicable diseases of long duration such as a cardiovascular disease or cancer, mental health conditions such as mood disorder or dementia, or infectious diseases such as HIV/AIDS or viral hepatitis.</p><p id="Par19">Resulting LTCs are listed in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>. This list includes, conventional stroke risk factors such as coronary heart disease, hypertension, and diabetes, but also LTCs a priori less related or non-directly related to stroke such as cancers, chronic kidney disease (CKD), asthma, and chronic obstructive pulmonary disease (COPD). Patient&#8217;s EHRs included the date at which any of the considered LTCs were first ever recorded. All patients with a record of stroke were deemed eligible for this study, regardless their number of recorded LTCs.
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Long-term conditions analysed: long-term conditions are classified according to the 10<sup>th</sup> international classification of diseases (ICD-10)</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">No.</th><th align="left" colspan="1" rowspan="1">Category</th><th align="left" colspan="1" rowspan="1">ICD-10 code</th><th align="left" colspan="1" rowspan="1">Long-term condition</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">1</td><td align="left" colspan="1" rowspan="1">Neoplasms</td><td align="left" colspan="1" rowspan="1">C00-C97</td><td align="left" colspan="1" rowspan="1">Cancer</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" rowspan="8" colspan="1">Diseases of the circulatory system</td><td align="left" colspan="1" rowspan="1">I48</td><td align="left" colspan="1" rowspan="1">Atrial Fibrillation</td></tr><tr><td align="left" colspan="1" rowspan="1">3</td><td align="left" colspan="1" rowspan="1">I50</td><td align="left" colspan="1" rowspan="1">Heart Failure</td></tr><tr><td align="left" colspan="1" rowspan="1">4</td><td align="left" colspan="1" rowspan="1">I10</td><td align="left" colspan="1" rowspan="1">Hypertension</td></tr><tr><td align="left" colspan="1" rowspan="1">5</td><td align="left" colspan="1" rowspan="1">I21</td><td align="left" colspan="1" rowspan="1">Myocardial infarction</td></tr><tr><td align="left" colspan="1" rowspan="1">6</td><td align="left" colspan="1" rowspan="1">I73</td><td align="left" colspan="1" rowspan="1">Peripheral Aterial/Vascular Disease</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">G45</td><td align="left" colspan="1" rowspan="1">Transient cerebral ischemic attacks (TIA)</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">I60-I64</td><td align="left" colspan="1" rowspan="1">Stroke</td></tr><tr><td align="left" colspan="1" rowspan="1">9</td><td align="left" colspan="1" rowspan="1">I20-I25</td><td align="left" colspan="1" rowspan="1">Coronary Heart Disease</td></tr><tr><td align="left" colspan="1" rowspan="1">10</td><td align="left" rowspan="2" colspan="1">Certain infectious and parasitic diseases</td><td align="left" colspan="1" rowspan="1">B15-B19</td><td align="left" colspan="1" rowspan="1">Viral Hepatitis (B&amp;C)</td></tr><tr><td align="left" colspan="1" rowspan="1">11</td><td align="left" colspan="1" rowspan="1">B20</td><td align="left" colspan="1" rowspan="1">HIV/AIDS</td></tr><tr><td align="left" colspan="1" rowspan="1">12</td><td align="left" colspan="1" rowspan="1">Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism</td><td align="left" colspan="1" rowspan="1">D57</td><td align="left" colspan="1" rowspan="1">Sickle Cell Anaemia</td></tr><tr><td align="left" colspan="1" rowspan="1">13</td><td align="left" colspan="1" rowspan="1">Endocrine, nutritional and metabolic diseases</td><td align="left" colspan="1" rowspan="1">E10-E14</td><td align="left" colspan="1" rowspan="1">Diabetes</td></tr><tr><td align="left" colspan="1" rowspan="1">14</td><td align="left" rowspan="4" colspan="1">Mental, Behavioral and Neurodevelopmental disorders</td><td align="left" colspan="1" rowspan="1">F32</td><td align="left" colspan="1" rowspan="1">Depression</td></tr><tr><td align="left" colspan="1" rowspan="1">15</td><td align="left" colspan="1" rowspan="1">F40-F41</td><td align="left" colspan="1" rowspan="1">Anxiety Disorders</td></tr><tr><td align="left" colspan="1" rowspan="1">16</td><td align="left" colspan="1" rowspan="1">F20-F29</td><td align="left" colspan="1" rowspan="1">Serious Mental Illness</td></tr><tr><td align="left" colspan="1" rowspan="1">17</td><td align="left" colspan="1" rowspan="1">F00-F03, G30</td><td align="left" colspan="1" rowspan="1">Dementia/Alzheimer&#8217;s</td></tr><tr><td align="left" colspan="1" rowspan="1">18</td><td align="left" rowspan="3" colspan="1">Diseases of the nervous system</td><td align="left" colspan="1" rowspan="1">G40-G41</td><td align="left" colspan="1" rowspan="1">Epilepsy</td></tr><tr><td align="left" colspan="1" rowspan="1">19</td><td align="left" colspan="1" rowspan="1">G20</td><td align="left" colspan="1" rowspan="1">Parkinson&#8217;s disease</td></tr><tr><td align="left" colspan="1" rowspan="1">20</td><td align="left" colspan="1" rowspan="1">G35</td><td align="left" colspan="1" rowspan="1">Multiple Sclerosis</td></tr><tr><td align="left" colspan="1" rowspan="1">21</td><td align="left" rowspan="2" colspan="1">Diseases of the respiratory system</td><td align="left" colspan="1" rowspan="1">J45-J46</td><td align="left" colspan="1" rowspan="1">Asthma</td></tr><tr><td align="left" colspan="1" rowspan="1">22</td><td align="left" colspan="1" rowspan="1">J44</td><td align="left" colspan="1" rowspan="1">Chronic Obstructive Pulmonary Disease (COPD)</td></tr><tr><td align="left" colspan="1" rowspan="1">23</td><td align="left" rowspan="2" colspan="1">Diseases of the digestive system</td><td align="left" colspan="1" rowspan="1">K50-K52</td><td align="left" colspan="1" rowspan="1">Inflammatory Bowel Disease</td></tr><tr><td align="left" colspan="1" rowspan="1">24</td><td align="left" colspan="1" rowspan="1">K70-K76</td><td align="left" colspan="1" rowspan="1">Liver Disease</td></tr><tr><td align="left" colspan="1" rowspan="1">25</td><td align="left" colspan="1" rowspan="1">Diseases of the genitourinary system</td><td align="left" colspan="1" rowspan="1">N18</td><td align="left" colspan="1" rowspan="1">Chronic kidney disease stage 3 to stage 5 (CKD 3-5)</td></tr><tr><td align="left" colspan="1" rowspan="1">26</td><td align="left" rowspan="3" colspan="1">Diseases of the musculoskeletal system and connective tissue</td><td align="left" colspan="1" rowspan="1">M05-M06</td><td align="left" colspan="1" rowspan="1">Rheumatoid Arthritis</td></tr><tr><td align="left" colspan="1" rowspan="1">27</td><td align="left" colspan="1" rowspan="1">M15-M19</td><td align="left" colspan="1" rowspan="1">Osteoarthritis</td></tr><tr><td align="left" colspan="1" rowspan="1">28</td><td align="left" colspan="1" rowspan="1">M80-M82</td><td align="left" colspan="1" rowspan="1">Osteoporosis</td></tr><tr><td align="left" colspan="1" rowspan="1">29</td><td align="left" colspan="1" rowspan="1">Diseases of the musculoskeletal system and connective tissue</td><td align="left" colspan="1" rowspan="1">M32</td><td align="left" colspan="1" rowspan="1">Lupus</td></tr><tr><td align="left" colspan="1" rowspan="1">30</td><td align="left" colspan="1" rowspan="1">Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified</td><td align="left" colspan="1" rowspan="1">R41.83</td><td align="left" colspan="1" rowspan="1">Cognitive and learning disability</td></tr></tbody></table></table-wrap></p><p id="Par20">Associated socio-demographic variables were gender (self ascribed), age at record of stroke, ethnicity (Asian ethnicity, Black ethnicity, mixed ethnicity, other/unknown ethnicity, and White ethnicity), quintile of the locally calculated index of multiple deprivation (IMD) 2019, and end of follow-up status (censoring or death). Censoring referred to administrative censoring for patients who were still under follow-up at the censoring point. It also applied to patients who had left (alive) the network of Lambeth general practices before the censoring point.</p><p id="Par21">Other variables/risk factors were smoking ever status, alcohol consumption (over 14 units of alcohol per week), substance use/dependency, chronic pain, hypercholesterolaemia (total cholesterol over 5.0 mmol/L) and morbid obesity.</p></sec><sec id="Sec4"><title>Clustering analysis</title><p id="Par22">Individual patients&#8217; records were analysed using a patient-oriented clustering approach based on the Ward&#8217;s minimum variance criterion. This involves the three following steps [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR22">22</xref>]: i) computation of pairwise distances between patients, ii) computation of the hierarchical clustering, and iii) determination of the size of the typology (Fig. <xref rid="Fig1" ref-type="fig">1</xref>).<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Study workflow</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="12875_2024_2636_Fig1_HTML.jpg"/></fig></p><p id="Par23">In order to account for the multiplicity of time-to-event censored endpoints in patients with multimorbidity, individual patient records were converted into state matrices prior to pairwise distances computations. These matrices stack patients&#8217; state indicators across all analyzed LTCs. For instance, if a patient is diagnosed with hypertension at age 60, their state indicator for hypertension would be 0 from age 0 to 59, change to 1 from age 60 until the patient&#8217;s death or censoring, and would remain undefined thereafter. Therefore, one patient state matrix is formed by as many rows as the number of analyzed LTCs, and ranges from age 0 to the most advance age at end of follow up in the cohort. Simplified examples of states matrices are displayed in supplementary figure S2. Given patients&#8217; state matrices, patients&#8217; pairwise dissimilarities were computed elementwise using the Jaccard distance [<xref ref-type="bibr" rid="CR23">23</xref>]. Also referred to as the binary metric, the Jaccard distance is a measure of dissimilarity between binary outcomes, such as state indicators. It is defined as one minus the Jaccard index, which is conversely a measure of similarity between sets. The Jaccard index between two indicators is computed as the number of positive matching units of time over the number of units either indicator has been positive and takes therefore values between 0 and 1. The Jaccard index offers a meaningful epidemiological interpretation: it quantifies, for two patients with a given long-term condition, the number of years these patients were in differing health states throughout the period when either patient had a recorded history of the disease. Consequently, the longer two patients remained in the same state of health, the lower the Jaccard index, increasing the likelihood of their co-clustering, a result that aligns with expectations. To provide a clearer understanding of how patients&#8217; pairwise distances are computed using state matrices and the Jaccard distance, detailed examples are available in the supplementary materials. To better illustrate patients pairwise distance computation using state matrices and the Jaccard distance, detailed examples are provided in supplementary materials.</p><p id="Par24">After computation of the Ward&#8217;s hierarchical clustering, the point-biserial correlation [<xref ref-type="bibr" rid="CR21">21</xref>] was used to determine the optimal size of the typology within a convenient and workable range (from two to 20 clusters). For a given partition size, this indicator reflects the correlation between the original distance matrix (the distance matrix actually used to compute the hierarchical clustering), and a twin binary matrix in which entries are set to zero for any pair of patients belonging the the same cluster (given the tested partition), and one otherwise. Therefore, the higher the point-biserial correlation, the closer the actual distance matrix to its binary twin matrix, and the better the tested partition reflects the underlying structure of the data. A local maximum of this coefficient across the range of tested partition size indicates an optimal partition size according to this criterion. Bootstrap was used to evaluate the variability of the point-biserial correlation for a range typology size and for different subset size.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par25">LTCs, socio-demographic variables and other variables, were displayed as frequencies and percentage or median and interquartile range as appropriate. Associations between variables and clusters were tested using the Fisher exact test for categorical variables or the Kruskal-Wallis test for numeric variables (Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>). Multivariate associations between clusters and socio-demographic variables, stroke risk factors, and LTCs were estimated using logistic regressions where cluster indicators were explained by tested variables (Figs. <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Distribution of socio-demographics and risk factors associated to stroke accross the clusters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Cluster #</th><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1">1</th><th align="left" colspan="1" rowspan="1">2</th><th align="left" colspan="1" rowspan="1">3</th><th align="left" colspan="1" rowspan="1">4</th><th align="left" colspan="1" rowspan="1">5</th><th align="left" colspan="1" rowspan="1">6</th><th align="left" colspan="1" rowspan="1">7</th><th align="left" colspan="1" rowspan="1">8</th><th align="left" colspan="1" rowspan="1">Total</th><th align="left" colspan="1" rowspan="1">P</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Gender</td><td align="left" colspan="1" rowspan="1">Female</td><td align="left" colspan="1" rowspan="1">1025 (42.9)</td><td align="left" colspan="1" rowspan="1">969 (53.4)</td><td align="left" colspan="1" rowspan="1">729 (40.9)</td><td align="left" colspan="1" rowspan="1">581 (41.2)</td><td align="left" colspan="1" rowspan="1">463 (54.8)</td><td align="left" colspan="1" rowspan="1">404 (59.0)</td><td align="left" colspan="1" rowspan="1">271 (48.1)</td><td align="left" colspan="1" rowspan="1">133 (37.3)</td><td align="left" colspan="1" rowspan="1">4575 (46.5)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Age at onset</td><td align="left" colspan="1" rowspan="1">Median (IQR)</td><td align="left" colspan="1" rowspan="1">59.2 (52.6 to 68.0)</td><td align="left" colspan="1" rowspan="1">81.2 (76.1 to 86.3)</td><td align="left" colspan="1" rowspan="1">70.7 (65.8 to 77.0)</td><td align="left" colspan="1" rowspan="1">55.0 (49.0 to 63.0)</td><td align="left" colspan="1" rowspan="1">47.0 (36.0 to 56.9)</td><td align="left" colspan="1" rowspan="1">78.1 (69.5 to 85.4)</td><td align="left" colspan="1" rowspan="1">26.8 (19.2 to 32.0)</td><td align="left" colspan="1" rowspan="1">44.4 (41.1 to 47.0)</td><td align="left" colspan="1" rowspan="1">65.0 (51.5 to 77.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Ethnicity</td><td align="left" colspan="1" rowspan="1">White</td><td align="left" colspan="1" rowspan="1">1284 (53.7)</td><td align="left" colspan="1" rowspan="1">1088 (60.0)</td><td align="left" colspan="1" rowspan="1">830 (46.6)</td><td align="left" colspan="1" rowspan="1">441 (31.3)</td><td align="left" colspan="1" rowspan="1">497 (58.8)</td><td align="left" colspan="1" rowspan="1">361 (52.7)</td><td align="left" colspan="1" rowspan="1">307 (54.5)</td><td align="left" colspan="1" rowspan="1">191 (53.5)</td><td align="left" colspan="1" rowspan="1">4999 (50.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Asian</td><td align="left" colspan="1" rowspan="1">147 (6.1)</td><td align="left" colspan="1" rowspan="1">103 (5.7)</td><td align="left" colspan="1" rowspan="1">138 (7.7)</td><td align="left" colspan="1" rowspan="1">131 (9.3)</td><td align="left" colspan="1" rowspan="1">42 (5.0)</td><td align="left" colspan="1" rowspan="1">43 (6.3)</td><td align="left" colspan="1" rowspan="1">21 (3.7)</td><td align="left" colspan="1" rowspan="1">20 (5.6)</td><td align="left" colspan="1" rowspan="1">645 (6.6)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Black</td><td align="left" colspan="1" rowspan="1">550 (23.0)</td><td align="left" colspan="1" rowspan="1">268 (14.8)</td><td align="left" colspan="1" rowspan="1">485 (27.2)</td><td align="left" colspan="1" rowspan="1">619 (43.9)</td><td align="left" colspan="1" rowspan="1">185 (21.9)</td><td align="left" colspan="1" rowspan="1">168 (24.5)</td><td align="left" colspan="1" rowspan="1">128 (22.7)</td><td align="left" colspan="1" rowspan="1">92 (25.8)</td><td align="left" colspan="1" rowspan="1">2495 (25.3)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Mixed</td><td align="left" colspan="1" rowspan="1">78 (3.3)</td><td align="left" colspan="1" rowspan="1">33 (1.8)</td><td align="left" colspan="1" rowspan="1">54 (3.0)</td><td align="left" colspan="1" rowspan="1">52 (3.7)</td><td align="left" colspan="1" rowspan="1">32 (3.8)</td><td align="left" colspan="1" rowspan="1">20 (2.9)</td><td align="left" colspan="1" rowspan="1">30 (5.3)</td><td align="left" colspan="1" rowspan="1">14 (3.9)</td><td align="left" colspan="1" rowspan="1">313 (3.2)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">Other/Unknown</td><td align="left" colspan="1" rowspan="1">333 (13.9)</td><td align="left" colspan="1" rowspan="1">322 (17.8)</td><td align="left" colspan="1" rowspan="1">275 (15.4)</td><td align="left" colspan="1" rowspan="1">166 (11.8)</td><td align="left" colspan="1" rowspan="1">89 (10.5)</td><td align="left" colspan="1" rowspan="1">93 (13.6)</td><td align="left" colspan="1" rowspan="1">77 (13.7)</td><td align="left" colspan="1" rowspan="1">40 (11.2)</td><td align="left" colspan="1" rowspan="1">1395 (14.2)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">&lt;3 - Most deprived</td><td align="left" colspan="1" rowspan="1">1638 (68.5)</td><td align="left" colspan="1" rowspan="1">1190 (65.6)</td><td align="left" colspan="1" rowspan="1">1192 (66.9)</td><td align="left" colspan="1" rowspan="1">1038 (73.7)</td><td align="left" colspan="1" rowspan="1">568 (67.2)</td><td align="left" colspan="1" rowspan="1">451 (65.8)</td><td align="left" colspan="1" rowspan="1">372 (66.1)</td><td align="left" colspan="1" rowspan="1">232 (65.0)</td><td align="left" colspan="1" rowspan="1">6681 (67.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">IMD quintile</td><td align="left" colspan="1" rowspan="1">&gt;2 - Least deprived</td><td align="left" colspan="1" rowspan="1">736 (30.8)</td><td align="left" colspan="1" rowspan="1">611 (33.7)</td><td align="left" colspan="1" rowspan="1">579 (32.5)</td><td align="left" colspan="1" rowspan="1">366 (26.0)</td><td align="left" colspan="1" rowspan="1">270 (32.0)</td><td align="left" colspan="1" rowspan="1">228 (33.3)</td><td align="left" colspan="1" rowspan="1">182 (32.3)</td><td align="left" colspan="1" rowspan="1">116 (32.5)</td><td align="left" colspan="1" rowspan="1">3088 (31.4)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">(Missing)</td><td align="left" colspan="1" rowspan="1">18 (0.8)</td><td align="left" colspan="1" rowspan="1">13 (0.7)</td><td align="left" colspan="1" rowspan="1">11 (0.6)</td><td align="left" colspan="1" rowspan="1">5 (0.4)</td><td align="left" colspan="1" rowspan="1">7 (0.8)</td><td align="left" colspan="1" rowspan="1">6 (0.9)</td><td align="left" colspan="1" rowspan="1">9 (1.6)</td><td align="left" colspan="1" rowspan="1">9 (2.5)</td><td align="left" colspan="1" rowspan="1">78 (0.8)</td><td align="left" colspan="1" rowspan="1"/></tr><tr><td align="left" colspan="1" rowspan="1">Smoking ever</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">1610 (67.3)</td><td align="left" colspan="1" rowspan="1">1044 (57.6)</td><td align="left" colspan="1" rowspan="1">1059 (59.4)</td><td align="left" colspan="1" rowspan="1">850 (60.3)</td><td align="left" colspan="1" rowspan="1">588 (69.6)</td><td align="left" colspan="1" rowspan="1">378 (55.2)</td><td align="left" colspan="1" rowspan="1">261 (46.4)</td><td align="left" colspan="1" rowspan="1">210 (58.8)</td><td align="left" colspan="1" rowspan="1">6000 (60.9)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Substance dependancy</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">215 (9.0)</td><td align="left" colspan="1" rowspan="1">39 (2.1)</td><td align="left" colspan="1" rowspan="1">43 (2.4)</td><td align="left" colspan="1" rowspan="1">57 (4.0)</td><td align="left" colspan="1" rowspan="1">177 (20.9)</td><td align="left" colspan="1" rowspan="1">22 (3.2)</td><td align="left" colspan="1" rowspan="1">38 (6.7)</td><td align="left" colspan="1" rowspan="1">18 (5.0)</td><td align="left" colspan="1" rowspan="1">609 (6.2)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Alcohol dependence</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">744 (31.1)</td><td align="left" colspan="1" rowspan="1">330 (18.2)</td><td align="left" colspan="1" rowspan="1">416 (23.3)</td><td align="left" colspan="1" rowspan="1">326 (23.1)</td><td align="left" colspan="1" rowspan="1">296 (35.0)</td><td align="left" colspan="1" rowspan="1">151 (22.0)</td><td align="left" colspan="1" rowspan="1">94 (16.7)</td><td align="left" colspan="1" rowspan="1">88 (24.6)</td><td align="left" colspan="1" rowspan="1">2445 (24.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic pain</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">1440 (60.2)</td><td align="left" colspan="1" rowspan="1">1060 (58.4)</td><td align="left" colspan="1" rowspan="1">988 (55.4)</td><td align="left" colspan="1" rowspan="1">810 (57.5)</td><td align="left" colspan="1" rowspan="1">521 (61.7)</td><td align="left" colspan="1" rowspan="1">589 (86.0)</td><td align="left" colspan="1" rowspan="1">104 (18.5)</td><td align="left" colspan="1" rowspan="1">90 (25.2)</td><td align="left" colspan="1" rowspan="1">5602 (56.9)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypercholesterolemia</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">1738 (72.7)</td><td align="left" colspan="1" rowspan="1">1248 (68.8)</td><td align="left" colspan="1" rowspan="1">1342 (75.3)</td><td align="left" colspan="1" rowspan="1">1100 (78.1)</td><td align="left" colspan="1" rowspan="1">537 (63.6)</td><td align="left" colspan="1" rowspan="1">517 (75.5)</td><td align="left" colspan="1" rowspan="1">136 (24.2)</td><td align="left" colspan="1" rowspan="1">195 (54.6)</td><td align="left" colspan="1" rowspan="1">6813 (69.2)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Morbid obesity</td><td align="left" colspan="1" rowspan="1">Yes</td><td align="left" colspan="1" rowspan="1">156 (6.5)</td><td align="left" colspan="1" rowspan="1">51 (2.8)</td><td align="left" colspan="1" rowspan="1">90 (5.1)</td><td align="left" colspan="1" rowspan="1">177 (12.6)</td><td align="left" colspan="1" rowspan="1">94 (11.1)</td><td align="left" colspan="1" rowspan="1">46 (6.7)</td><td align="left" colspan="1" rowspan="1">11 (2.0)</td><td align="left" colspan="1" rowspan="1">12 (3.4)</td><td align="left" colspan="1" rowspan="1">637 (6.5)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">No. LTC<sup>b</sup></td><td align="left" colspan="1" rowspan="1">Median (IQR)</td><td align="left" colspan="1" rowspan="1">4.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">4.0 (3.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">0.0 (0.0 to 1.0)</td><td align="left" colspan="1" rowspan="1">0.0 (0.0 to 1.0)</td><td align="left" colspan="1" rowspan="1">3.0 (2.0 to 5.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Medication count</td><td align="left" colspan="1" rowspan="1">Median (IQR)</td><td align="left" colspan="1" rowspan="1">5.0 (3.0 to 8.5)</td><td align="left" colspan="1" rowspan="1">6.0 (4.0 to 9.0)</td><td align="left" colspan="1" rowspan="1">5.5 (3.0 to 9.0)</td><td align="left" colspan="1" rowspan="1">5.0 (3.0 to 8.5)</td><td align="left" colspan="1" rowspan="1">4.0 (3.0 to 7.0)</td><td align="left" colspan="1" rowspan="1">6.0 (4.0 to 10.0)</td><td align="left" colspan="1" rowspan="1">2.0 (1.0 to 3.0)</td><td align="left" colspan="1" rowspan="1">2.5 (1.5 to 5.0)</td><td align="left" colspan="1" rowspan="1">5.0 (3.0 to 8.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Total N (%)</td><td align="left" colspan="1" rowspan="1"/><td align="left" colspan="1" rowspan="1">2392 (24.3)</td><td align="left" colspan="1" rowspan="1">1814 (18.4)</td><td align="left" colspan="1" rowspan="1">1782 (18.1)</td><td align="left" colspan="1" rowspan="1">1409 (14.3)</td><td align="left" colspan="1" rowspan="1">845 (8.6)</td><td align="left" colspan="1" rowspan="1">685 (7.0)</td><td align="left" colspan="1" rowspan="1">563 (5.7)</td><td align="left" colspan="1" rowspan="1">357 (3.6)</td><td align="left" colspan="1" rowspan="1">9847</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table><table-wrap-foot><p><sup>a</sup> IMD<sup>a</sup> quitile 1 (most deprived)-2 vs 3-5 (less deprived)</p><p>
<sup>b</sup> Long-term condition</p></table-wrap-foot></table-wrap><table-wrap id="Tab3" position="float" orientation="portrait"><label>Table 3</label><caption><p>Distribution of the 30 analysed long-term conditions across defined clusters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Cluster #</th><th align="left" colspan="1" rowspan="1">1</th><th align="left" colspan="1" rowspan="1">2</th><th align="left" colspan="1" rowspan="1">3</th><th align="left" colspan="1" rowspan="1">4</th><th align="left" colspan="1" rowspan="1">5</th><th align="left" colspan="1" rowspan="1">6</th><th align="left" colspan="1" rowspan="1">7</th><th align="left" colspan="1" rowspan="1">8</th><th align="left" colspan="1" rowspan="1">Total</th><th align="left" colspan="1" rowspan="1">P</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Coronary Heart Disease</td><td align="left" colspan="1" rowspan="1">419 (17.5)</td><td align="left" colspan="1" rowspan="1">335 (18.5)</td><td align="left" colspan="1" rowspan="1">382 (21.4)</td><td align="left" colspan="1" rowspan="1">267 (18.9)</td><td align="left" colspan="1" rowspan="1">84 (9.9)</td><td align="left" colspan="1" rowspan="1">140 (20.4)</td><td align="left" colspan="1" rowspan="1">10 (1.8)</td><td align="left" colspan="1" rowspan="1">19 (5.3)</td><td align="left" colspan="1" rowspan="1">1656 (16.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Parkinson&#8217;s disease</td><td align="left" colspan="1" rowspan="1">61 (2.6)</td><td align="left" colspan="1" rowspan="1">58 (3.2)</td><td align="left" colspan="1" rowspan="1">39 (2.2)</td><td align="left" colspan="1" rowspan="1">16 (1.1)</td><td align="left" colspan="1" rowspan="1">5 (0.6)</td><td align="left" colspan="1" rowspan="1">17 (2.5)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">2 (0.6)</td><td align="left" colspan="1" rowspan="1">198 (2.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Heart Failure</td><td align="left" colspan="1" rowspan="1">296 (12.4)</td><td align="left" colspan="1" rowspan="1">264 (14.6)</td><td align="left" colspan="1" rowspan="1">278 (15.6)</td><td align="left" colspan="1" rowspan="1">190 (13.5)</td><td align="left" colspan="1" rowspan="1">63 (7.5)</td><td align="left" colspan="1" rowspan="1">113 (16.5)</td><td align="left" colspan="1" rowspan="1">12 (2.1)</td><td align="left" colspan="1" rowspan="1">7 (2.0)</td><td align="left" colspan="1" rowspan="1">1223 (12.4)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Osteoarthritis</td><td align="left" colspan="1" rowspan="1">566 (23.7)</td><td align="left" colspan="1" rowspan="1">401 (22.1)</td><td align="left" colspan="1" rowspan="1">421 (23.6)</td><td align="left" colspan="1" rowspan="1">324 (23.0)</td><td align="left" colspan="1" rowspan="1">138 (16.3)</td><td align="left" colspan="1" rowspan="1">683 (99.7)</td><td align="left" colspan="1" rowspan="1">26 (4.6)</td><td align="left" colspan="1" rowspan="1">24 (6.7)</td><td align="left" colspan="1" rowspan="1">2583 (26.2)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Asthma</td><td align="left" colspan="1" rowspan="1">441 (18.4)</td><td align="left" colspan="1" rowspan="1">244 (13.5)</td><td align="left" colspan="1" rowspan="1">79 (4.4)</td><td align="left" colspan="1" rowspan="1">72 (5.1)</td><td align="left" colspan="1" rowspan="1">342 (40.5)</td><td align="left" colspan="1" rowspan="1">38 (5.5)</td><td align="left" colspan="1" rowspan="1">27 (4.8)</td><td align="left" colspan="1" rowspan="1">12 (3.4)</td><td align="left" colspan="1" rowspan="1">1255 (12.7)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Serious Mental Illness</td><td align="left" colspan="1" rowspan="1">280 (11.7)</td><td align="left" colspan="1" rowspan="1">50 (2.8)</td><td align="left" colspan="1" rowspan="1">26 (1.5)</td><td align="left" colspan="1" rowspan="1">32 (2.3)</td><td align="left" colspan="1" rowspan="1">46 (5.4)</td><td align="left" colspan="1" rowspan="1">2 (0.3)</td><td align="left" colspan="1" rowspan="1">16 (2.8)</td><td align="left" colspan="1" rowspan="1">7 (2.0)</td><td align="left" colspan="1" rowspan="1">459 (4.7)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">1430 (59.8)</td><td align="left" colspan="1" rowspan="1">1206 (66.5)</td><td align="left" colspan="1" rowspan="1">1424 (79.9)</td><td align="left" colspan="1" rowspan="1">1301 (92.3)</td><td align="left" colspan="1" rowspan="1">352 (41.7)</td><td align="left" colspan="1" rowspan="1">485 (70.8)</td><td align="left" colspan="1" rowspan="1">64 (11.4)</td><td align="left" colspan="1" rowspan="1">82 (23.0)</td><td align="left" colspan="1" rowspan="1">6344 (64.4)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression</td><td align="left" colspan="1" rowspan="1">844 (35.3)</td><td align="left" colspan="1" rowspan="1">317 (17.5)</td><td align="left" colspan="1" rowspan="1">200 (11.2)</td><td align="left" colspan="1" rowspan="1">274 (19.4)</td><td align="left" colspan="1" rowspan="1">531 (62.8)</td><td align="left" colspan="1" rowspan="1">84 (12.3)</td><td align="left" colspan="1" rowspan="1">64 (11.4)</td><td align="left" colspan="1" rowspan="1">26 (7.3)</td><td align="left" colspan="1" rowspan="1">2340 (23.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Anxiety Disorders</td><td align="left" colspan="1" rowspan="1">517 (21.6)</td><td align="left" colspan="1" rowspan="1">329 (18.1)</td><td align="left" colspan="1" rowspan="1">146 (8.2)</td><td align="left" colspan="1" rowspan="1">233 (16.5)</td><td align="left" colspan="1" rowspan="1">570 (67.5)</td><td align="left" colspan="1" rowspan="1">91 (13.3)</td><td align="left" colspan="1" rowspan="1">79 (14.0)</td><td align="left" colspan="1" rowspan="1">23 (6.4)</td><td align="left" colspan="1" rowspan="1">1988 (20.2)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Cancer</td><td align="left" colspan="1" rowspan="1">460 (19.2)</td><td align="left" colspan="1" rowspan="1">387 (21.3)</td><td align="left" colspan="1" rowspan="1">351 (19.7)</td><td align="left" colspan="1" rowspan="1">133 (9.4)</td><td align="left" colspan="1" rowspan="1">85 (10.1)</td><td align="left" colspan="1" rowspan="1">88 (12.8)</td><td align="left" colspan="1" rowspan="1">9 (1.6)</td><td align="left" colspan="1" rowspan="1">25 (7.0)</td><td align="left" colspan="1" rowspan="1">1538 (15.6)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Peripheral Aterial/Vascular Disease</td><td align="left" colspan="1" rowspan="1">169 (7.1)</td><td align="left" colspan="1" rowspan="1">111 (6.1)</td><td align="left" colspan="1" rowspan="1">181 (10.2)</td><td align="left" colspan="1" rowspan="1">113 (8.0)</td><td align="left" colspan="1" rowspan="1">25 (3.0)</td><td align="left" colspan="1" rowspan="1">52 (7.6)</td><td align="left" colspan="1" rowspan="1">1 (0.2)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">653 (6.6)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">626 (26.2)</td><td align="left" colspan="1" rowspan="1">409 (22.5)</td><td align="left" colspan="1" rowspan="1">710 (39.8)</td><td align="left" colspan="1" rowspan="1">831 (59.0)</td><td align="left" colspan="1" rowspan="1">177 (20.9)</td><td align="left" colspan="1" rowspan="1">190 (27.7)</td><td align="left" colspan="1" rowspan="1">26 (4.6)</td><td align="left" colspan="1" rowspan="1">37 (10.4)</td><td align="left" colspan="1" rowspan="1">3006 (30.5)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic Kidney Disease Stage 3-5</td><td align="left" colspan="1" rowspan="1">444 (18.6)</td><td align="left" colspan="1" rowspan="1">514 (28.3)</td><td align="left" colspan="1" rowspan="1">565 (31.7)</td><td align="left" colspan="1" rowspan="1">423 (30.0)</td><td align="left" colspan="1" rowspan="1">107 (12.7)</td><td align="left" colspan="1" rowspan="1">207 (30.2)</td><td align="left" colspan="1" rowspan="1">22 (3.9)</td><td align="left" colspan="1" rowspan="1">14 (3.9)</td><td align="left" colspan="1" rowspan="1">2296 (23.3)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Viral Hepatitis (B&amp;C)</td><td align="left" colspan="1" rowspan="1">105 (4.4)</td><td align="left" colspan="1" rowspan="1">10 (0.6)</td><td align="left" colspan="1" rowspan="1">9 (0.5)</td><td align="left" colspan="1" rowspan="1">21 (1.5)</td><td align="left" colspan="1" rowspan="1">23 (2.7)</td><td align="left" colspan="1" rowspan="1">6 (0.9)</td><td align="left" colspan="1" rowspan="1">6 (1.1)</td><td align="left" colspan="1" rowspan="1">5 (1.4)</td><td align="left" colspan="1" rowspan="1">185 (1.9)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Inflammatory Bowel Disease</td><td align="left" colspan="1" rowspan="1">58 (2.4)</td><td align="left" colspan="1" rowspan="1">23 (1.3)</td><td align="left" colspan="1" rowspan="1">16 (0.9)</td><td align="left" colspan="1" rowspan="1">18 (1.3)</td><td align="left" colspan="1" rowspan="1">19 (2.2)</td><td align="left" colspan="1" rowspan="1">14 (2.0)</td><td align="left" colspan="1" rowspan="1">4 (0.7)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">153 (1.6)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Liver Disease</td><td align="left" colspan="1" rowspan="1">99 (4.1)</td><td align="left" colspan="1" rowspan="1">17 (0.9)</td><td align="left" colspan="1" rowspan="1">14 (0.8)</td><td align="left" colspan="1" rowspan="1">22 (1.6)</td><td align="left" colspan="1" rowspan="1">37 (4.4)</td><td align="left" colspan="1" rowspan="1">6 (0.9)</td><td align="left" colspan="1" rowspan="1">3 (0.5)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">199 (2.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Epilepsy</td><td align="left" colspan="1" rowspan="1">378 (15.8)</td><td align="left" colspan="1" rowspan="1">58 (3.2)</td><td align="left" colspan="1" rowspan="1">61 (3.4)</td><td align="left" colspan="1" rowspan="1">66 (4.7)</td><td align="left" colspan="1" rowspan="1">71 (8.4)</td><td align="left" colspan="1" rowspan="1">38 (5.5)</td><td align="left" colspan="1" rowspan="1">46 (8.2)</td><td align="left" colspan="1" rowspan="1">14 (3.9)</td><td align="left" colspan="1" rowspan="1">732 (7.4)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Osteopotosis</td><td align="left" colspan="1" rowspan="1">94 (3.9)</td><td align="left" colspan="1" rowspan="1">206 (11.4)</td><td align="left" colspan="1" rowspan="1">118 (6.6)</td><td align="left" colspan="1" rowspan="1">29 (2.1)</td><td align="left" colspan="1" rowspan="1">23 (2.7)</td><td align="left" colspan="1" rowspan="1">67 (9.8)</td><td align="left" colspan="1" rowspan="1">2 (0.4)</td><td align="left" colspan="1" rowspan="1">5 (1.4)</td><td align="left" colspan="1" rowspan="1">544 (5.5)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Dementia/Alzheimer&#8217;s</td><td align="left" colspan="1" rowspan="1">277 (11.6)</td><td align="left" colspan="1" rowspan="1">460 (25.4)</td><td align="left" colspan="1" rowspan="1">352 (19.8)</td><td align="left" colspan="1" rowspan="1">132 (9.4)</td><td align="left" colspan="1" rowspan="1">42 (5.0)</td><td align="left" colspan="1" rowspan="1">172 (25.1)</td><td align="left" colspan="1" rowspan="1">4 (0.7)</td><td align="left" colspan="1" rowspan="1">12 (3.4)</td><td align="left" colspan="1" rowspan="1">1451 (14.7)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Sickle Cell Anaemia</td><td align="left" colspan="1" rowspan="1">11 (0.5)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">3 (0.2)</td><td align="left" colspan="1" rowspan="1">2 (0.2)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">41 (7.3)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">60 (0.6)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Multiple Sclerosis</td><td align="left" colspan="1" rowspan="1">12 (0.5)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">7 (0.8)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">2 (0.4)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">22 (0.2)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">HIV/AIDS</td><td align="left" colspan="1" rowspan="1">85 (3.6)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">3 (0.2)</td><td align="left" colspan="1" rowspan="1">10 (0.7)</td><td align="left" colspan="1" rowspan="1">11 (1.3)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">2 (0.4)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">113 (1.1)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Myocardial infarction</td><td align="left" colspan="1" rowspan="1">222 (9.3)</td><td align="left" colspan="1" rowspan="1">163 (9.0)</td><td align="left" colspan="1" rowspan="1">238 (13.4)</td><td align="left" colspan="1" rowspan="1">127 (9.0)</td><td align="left" colspan="1" rowspan="1">48 (5.7)</td><td align="left" colspan="1" rowspan="1">66 (9.6)</td><td align="left" colspan="1" rowspan="1">8 (1.4)</td><td align="left" colspan="1" rowspan="1">7 (2.0)</td><td align="left" colspan="1" rowspan="1">879 (8.9)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Atrial Fibrillation</td><td align="left" colspan="1" rowspan="1">365 (15.3)</td><td align="left" colspan="1" rowspan="1">491 (27.1)</td><td align="left" colspan="1" rowspan="1">388 (21.8)</td><td align="left" colspan="1" rowspan="1">141 (10.0)</td><td align="left" colspan="1" rowspan="1">74 (8.8)</td><td align="left" colspan="1" rowspan="1">184 (26.9)</td><td align="left" colspan="1" rowspan="1">13 (2.3)</td><td align="left" colspan="1" rowspan="1">16 (4.5)</td><td align="left" colspan="1" rowspan="1">1672 (17.0)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Lupus</td><td align="left" colspan="1" rowspan="1">34 (1.4)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">4 (0.2)</td><td align="left" colspan="1" rowspan="1">4 (0.3)</td><td align="left" colspan="1" rowspan="1">7 (0.8)</td><td align="left" colspan="1" rowspan="1">1 (0.1)</td><td align="left" colspan="1" rowspan="1">1 (0.2)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">52 (0.5)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Chronic Obstructive Pulmonary Disease</td><td align="left" colspan="1" rowspan="1">337 (14.1)</td><td align="left" colspan="1" rowspan="1">249 (13.7)</td><td align="left" colspan="1" rowspan="1">152 (8.5)</td><td align="left" colspan="1" rowspan="1">60 (4.3)</td><td align="left" colspan="1" rowspan="1">85 (10.1)</td><td align="left" colspan="1" rowspan="1">54 (7.9)</td><td align="left" colspan="1" rowspan="1">9 (1.6)</td><td align="left" colspan="1" rowspan="1">8 (2.2)</td><td align="left" colspan="1" rowspan="1">954 (9.7)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Rheumatoid Arthritis</td><td align="left" colspan="1" rowspan="1">89 (3.7)</td><td align="left" colspan="1" rowspan="1">29 (1.6)</td><td align="left" colspan="1" rowspan="1">19 (1.1)</td><td align="left" colspan="1" rowspan="1">29 (2.1)</td><td align="left" colspan="1" rowspan="1">15 (1.8)</td><td align="left" colspan="1" rowspan="1">21 (3.1)</td><td align="left" colspan="1" rowspan="1">2 (0.4)</td><td align="left" colspan="1" rowspan="1">1 (0.3)</td><td align="left" colspan="1" rowspan="1">205 (2.1)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Transient Ischemic Attack</td><td align="left" colspan="1" rowspan="1">443 (18.5)</td><td align="left" colspan="1" rowspan="1">283 (15.6)</td><td align="left" colspan="1" rowspan="1">425 (23.8)</td><td align="left" colspan="1" rowspan="1">165 (11.7)</td><td align="left" colspan="1" rowspan="1">109 (12.9)</td><td align="left" colspan="1" rowspan="1">111 (16.2)</td><td align="left" colspan="1" rowspan="1">12 (2.1)</td><td align="left" colspan="1" rowspan="1">9 (2.5)</td><td align="left" colspan="1" rowspan="1">1557 (15.8)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Cognitive and learning disability</td><td align="left" colspan="1" rowspan="1">49 (2.0)</td><td align="left" colspan="1" rowspan="1">2 (0.1)</td><td align="left" colspan="1" rowspan="1">3 (0.2)</td><td align="left" colspan="1" rowspan="1">9 (0.6)</td><td align="left" colspan="1" rowspan="1">9 (1.1)</td><td align="left" colspan="1" rowspan="1">2 (0.3)</td><td align="left" colspan="1" rowspan="1">11 (2.0)</td><td align="left" colspan="1" rowspan="1">0 (0.0)</td><td align="left" colspan="1" rowspan="1">85 (0.9)</td><td align="left" colspan="1" rowspan="1">&lt;0.001</td></tr><tr><td align="left" colspan="1" rowspan="1">Total N (%)</td><td align="left" colspan="1" rowspan="1">2392 (24.3)</td><td align="left" colspan="1" rowspan="1">1814 (18.4)</td><td align="left" colspan="1" rowspan="1">1782 (18.1)</td><td align="left" colspan="1" rowspan="1">1409 (14.3)</td><td align="left" colspan="1" rowspan="1">845 (8.6)</td><td align="left" colspan="1" rowspan="1">685 (7.0)</td><td align="left" colspan="1" rowspan="1">563 (5.7)</td><td align="left" colspan="1" rowspan="1">357 (3.6)</td><td align="left" colspan="1" rowspan="1">9847</td><td align="left" colspan="1" rowspan="1"/></tr></tbody></table></table-wrap></p><p id="Par26">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Heatmap of log-odds ratio of socio-demographic variables and conventional stroke risk factors (upper panel) and long-term conditions (lower panel) associated with defined clusters: in both panels, values are derived from multivariate logistic regressions where cluster indicators are explained by displayed variables. Positive log-odds ratios (red versus blue) indicate over representation of the corresponding population traits in a given cluster as compared to its conditional expectation. For better readability, coefficients associated with a significance level above 5% were not displayed</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="12875_2024_2636_Fig2_HTML.jpg"/></fig>
</p><p id="Par27">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Longitudinal representation of the main sequences characterising clusters of the typology: The main sequences between long-term conditions within clusters are represented by directed acyclic graphs (DAG) where nodes and edges represent long-term conditions and transition between them respectively. To get a better insight into sequences temporality, nodes are displayed according to median age at onset of the corresponding long-term condition, on the x-axis</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="12875_2024_2636_Fig3_HTML.jpg"/></fig>
</p><p id="Par28">All computations were carried out using the R language and environment for statistical computing (version 4.3.0 (2023-04-21))[<xref ref-type="bibr" rid="CR24">24</xref>].</p></sec></sec><sec id="Sec6"><title>Results</title><sec id="Sec7"><title>Patients characteristics and Long-term conditions</title><p id="Par29">Of 849,968 registered patients, 9,847 (1.16%) had a record of stroke. Table <xref rid="Tab2" ref-type="table">2</xref> displays patients socio-demographic characteristics across clusters. Briefly, the median age at record of stroke was 65.0 years, 46.5% of patients were female, 50.8% were from White ethnicity and 40.9% had an index of multiple deprivation (IMD) in quintile 1-2 (most deprived) (vs quintile 3-5 (less deprived)). Likewise, distribution of LTCs across clusters is displayed in Table <xref rid="Tab3" ref-type="table">3</xref>, hypertension (64.4%) and diabetes (30.5%) being the most frequently recorded LTCs. Other frequent LTCs were: osteoarthritis (26.2%), depression (23.8%), chronic kidney disease (23.3%), anxiety (20.2%), atrial fibrillation (17.0%), coronary heart disease (16.8%), transient ischemic attack (15.8%) and cancer (15.6%) (Table <xref rid="Tab2" ref-type="table">2</xref>). Supplementary figure S3 displays the scaled densities of patients&#8217; age at record of analysed LTCs. In addition to stroke, the median number of LTCs was 3 (interquartile range: from 2 to 5) (Table <xref rid="Tab3" ref-type="table">3</xref> and supplementary figure S4-A).</p></sec><sec id="Sec8"><title>Clustering</title><p id="Par30">After computation of patients pairwise dissimilarities, hierarchical clustering, and the point-biserial correlation, a local maximum of this coefficient indicated an optimal partition size of eight. Bootstrap (n=1000), performed on various sample size of the patient population (n=2500, 5000, 7500 and 9847) confirmed a partition of 8 clusters, although partition of size 7 or 11 clusters presented also overall high scores (supplementary figure S3). Accordingly, clusters were ordered by decreasing frequency and numbered from 1 to 8 (supplementary figure S4-B, and Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>).</p></sec><sec id="Sec9"><title>Clusters characteristics and graphical representations</title><p id="Par31">Table <xref rid="Tab2" ref-type="table">2</xref> displays the distribution of socio-demographic characteristics, risk factors, and the median number of medication across clusters, and Table <xref rid="Tab3" ref-type="table">3</xref> displays the distribution of LTCs across clusters. In analogy with supplementary figure S2, supplementary figure S3 displays the scaled densities of patients&#8217; age at record of analysed LTCs across clusters.</p><p id="Par32">Figure <xref rid="Fig2" ref-type="fig">2</xref> displays the multivariate log-odds ratios of socio-demographic characteristics and risk factors (upper panel) and LTCs (lower panel) across clusters, relatively to all other patients in the cohort. Finally, Fig. <xref rid="Fig3" ref-type="fig">3</xref> illustrates the backbone of the clusters by longitudinally mapping the main sequences of long-term conditions associated with stroke across different clusters. Associated sequence characteristics are displayed in Table <xref rid="Tab4" ref-type="table">4</xref>.
<table-wrap id="Tab4" position="float" orientation="portrait"><label>Table 4</label><caption><p>Main sequences of length 2 accross clusters</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="1" rowspan="1"/><th align="left" colspan="2" rowspan="1">Sequences</th><th align="left" colspan="2" rowspan="1">Statistics</th></tr><tr><th align="left" colspan="1" rowspan="1">Cluster#</th><th align="left" colspan="1" rowspan="1">Number of sequences<sup>a</sup></th><th align="left" colspan="1" rowspan="1">From</th><th align="left" colspan="1" rowspan="1">To</th><th align="left" colspan="1" rowspan="1">Support<sup>b</sup> (%)</th><th align="left" colspan="1" rowspan="1">Confidence<sup>c</sup> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="2" colspan="1">1</td><td align="left" rowspan="2" colspan="1">1334</td><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">41.3</td><td align="left" colspan="1" rowspan="1">69.1</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">25.7</td><td align="left" colspan="1" rowspan="1">72.7</td></tr><tr><td align="left" colspan="1" rowspan="1">2</td><td align="left" colspan="1" rowspan="1">1071</td><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">50.8</td><td align="left" colspan="1" rowspan="1">76.4</td></tr><tr><td align="left" rowspan="2" colspan="1">3</td><td align="left" rowspan="2" colspan="1">1106</td><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">60.9</td><td align="left" colspan="1" rowspan="1">76.3</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">28.0</td><td align="left" colspan="1" rowspan="1">70.3</td></tr><tr><td align="left" rowspan="2" colspan="1">4</td><td align="left" rowspan="2" colspan="1">1139</td><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">73.5</td><td align="left" colspan="1" rowspan="1">79.6</td></tr><tr><td align="left" colspan="1" rowspan="1">Diabetes</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">41.9</td><td align="left" colspan="1" rowspan="1">71.1</td></tr><tr><td align="left" rowspan="4" colspan="1">5</td><td align="left" rowspan="4" colspan="1">1185</td><td align="left" colspan="1" rowspan="1">Anxiety</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">55.5</td><td align="left" colspan="1" rowspan="1">82.3</td></tr><tr><td align="left" colspan="1" rowspan="1">Depression</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">51.8</td><td align="left" colspan="1" rowspan="1">82.5</td></tr><tr><td align="left" colspan="1" rowspan="1">Asthma</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">37.4</td><td align="left" colspan="1" rowspan="1">92.4</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">28.3</td><td align="left" colspan="1" rowspan="1">67.9</td></tr><tr><td align="left" rowspan="2" colspan="1">6</td><td align="left" rowspan="2" colspan="1">994</td><td align="left" colspan="1" rowspan="1">Osteoarthritis</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">93.1</td><td align="left" colspan="1" rowspan="1">93.4</td></tr><tr><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">58.1</td><td align="left" colspan="1" rowspan="1">82.1</td></tr><tr><td align="left" colspan="1" rowspan="1">7</td><td align="left" colspan="1" rowspan="1">723</td><td align="left" colspan="1" rowspan="1">Sickle Cell Anaemia</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">6.4</td><td align="left" colspan="1" rowspan="1">87.8</td></tr><tr><td align="left" colspan="1" rowspan="1">8</td><td align="left" colspan="1" rowspan="1">641</td><td align="left" colspan="1" rowspan="1">Stroke</td><td align="left" colspan="1" rowspan="1">Hypertension</td><td align="left" colspan="1" rowspan="1">23.0</td><td align="left" colspan="1" rowspan="1">23.0</td></tr></tbody></table><table-wrap-foot><p><sup>a</sup> Number of sequences of size 2 observed in the corresponding cluster</p><p>
<sup>b</sup> Proportion of patients presenting the sequence</p><p>
<sup>c</sup> Propotion of patients diagnosed with the second long-term condition given the first condition has been diagnosed</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec10"><title>Clusters examination</title><p id="Par33">Using Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, and Figs. <xref rid="Fig2" ref-type="fig">2</xref> and <xref rid="Fig3" ref-type="fig">3</xref>, defined clusters can be characterised as follow:<list list-type="bullet"><list-item><p id="Par34">Cluster 1 (n=2392, 24.3%) is the major cluster of the typology, accounting for almost a quarter of patients. This cluster displays average socio-demographic characteristics and a high prevalence of substances dependency (including smoking and alcohol), hypercholesterolaemia and a higher number of LTCs in addition to stroke (median: 4), including cancer, infectious and inflammatory diseases, mental health conditions, and diseases of the respiratory system.</p></list-item><list-item><p id="Par35">Cluster 2 (n=1814, 18.4%) is characterised by the oldest median age at record of stroke (81.2 years) and under-representation of Asian and Black ethnicity. In contrast to cluster 1, this cluster exhibits a reduced prevalence of alcohol and substance dependency, and hypercholesterolaemia while displaying LTCs characteristic of advanced age, such as cancer, atrial fibrillation, dementia, Parkinson&#8217;s, and osteoporosis. Additionally, COPD and CKD 3-5 are also prevalent in this cluster, whereas infectious and inflammatory diseases, mental health conditions, liver disease, and osteoarthritis are less represented.</p></list-item><list-item><p id="Par36">Cluster 3 (n=1782, 18.1%) is defined by an older median age at record of stroke (70.7 years), non-White ethnicity, and a higher proportion of male patients. This cluster presents also a high prevalence of hypercholesterolaemia. LTCs associated with this cluster include cancer, cardiovascular conditions, diabetes, dementia, and CKD 3-5. Similarly to cluster 2, cluster 3 has lower prevalence of infectious and inflammatory diseases, mental health conditions, liver disease, and osteoarthritis.</p></list-item><list-item><p id="Par37">Clusters 4 (n=1409, 14.3%) and 3 share similar socio-demographic characteristics. However, records of stroke occur earlier in cluster 4, at the median age of 55 years, compared to 70.7 years in cluster 3. Cluster 4 presents also the highest prevalence of hypertension (92.3%) and diabetes (59.0%) and a higher proportion of patients from Asian, Black and mixed ethnicity.</p></list-item><list-item><p id="Par38">Cluster 5 (n=845, 8.6%) is characterized by a younger median age at record of stroke (47 years), with an over-representation of female patients and patients from White ethnicity. This cluster displays also a higher prevalence of substances dependency (including smoking and alcohol) and chronic pain. Principal LTCs present in this cluster include depression, anxiety disorders, asthma, and liver disease.</p></list-item><list-item><p id="Par39">Cluster 6 (n=685, 6.7%) displays the second oldest median age at record of stroke (78.1 years) a slightly over representation of female patients. This cluster is also characterized by the highest prevalence of chronic pain and LTCs associated with older age, such as atrial fibrillation and dementia. Nearly all patients in this cluster were diagnosed with osteoarthritis.</p></list-item><list-item><p id="Par40">Cluster 7 (n=563, 5.7%) displays the youngest median age at record of stroke (26.8 years), average socio-demographic characteristics, and the lowest median number of LTCs. The majority of patients diagnosed with sickle cell anaemia belong to this cluster.</p></list-item><list-item><p id="Par41">Cluster 8 (n=357, 3.6%) presents similar socio-demographic characteristics to cluster 7, but with a later median age at record of stroke (44.4 years) and a high prevalence of hypercholesterolaemia.</p></list-item></list>Clusters 1 and 6 present the highest level of multimorbidity with a median of 4 recorded LTCs whereas clusters 2 to 5 present intermediate levels with a median of 3 recorded LTCs. One the other hand, clusters 7 and 8 present low profiles of multimorbidity, their median number of recorded LTC being zero (i.e., apart from stroke, no other LTCs were recorded for at least half of patients in these clusters) (Table <xref rid="Tab2" ref-type="table">2</xref>).</p></sec></sec><sec id="Sec11"><title>Discussion</title><p id="Par42">These results can be interpreted in various ways such as levels of patient complexity (clusters 1, 5 and 6), levels of conventional stroke risk factors (cluster 2-4) or levels of multimorbidity (clusters 1 and 6 vs. 7 and 8).</p><sec id="Sec12"><title>Multimorbidity and patient complexity (clusters 1, 5 and 6)</title><p id="Par43">Patient complexity is defined as a self-reinforced dynamic state in which the personal, social and clinical aspects of a patient experience interact [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. Multimorbidity impacts patient complexity [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR9">9</xref>] in various ways, such as the direct impact of LTCs on patient functional capacity (e.g., the limitation in usual activities due to osteoarthritis symptoms [<xref ref-type="bibr" rid="CR26">26</xref>] or mental health disorders [<xref ref-type="bibr" rid="CR27">27</xref>]) and the burden of treatment [<xref ref-type="bibr" rid="CR28">28</xref>]. If multimorbidity directly increases patient workload (burden of treatment), it may also differentially affect and erode patient capacity, according to specific patterns of multimorbidity (burden of illness).</p><p id="Par44">Clusters 1, 5 and 6, which display LTCs associated with high burden of illness, such as mental health disorders (clusters 1 and 5), and osteoarthritis (cluster 6) can be regarded as complex clusters. Especially, cluster 1 which displays a combination of mental health conditions, substances dependency and infectious diseases can be seen as even more complex than cluster 5, which lacks the infectious diseases pattern. Similarly, while cluster 6 displays the highest level of multimorbidity and level of medication, it can be seen as less complex than clusters 1 and 5, as it lacks the complexity signature formed by the combination substance dependency-mental health conditions.</p><p id="Par45">In addition, the socio-demographic and risk-factors characteristics of these clusters allows to identify other potential factors of complexity, such as the higher prevalence of substance dependency observed in clusters 1 and 5. These behavioural/lifestyle characteristics can be viewed not only as direct stroke risk factors [<xref ref-type="bibr" rid="CR29">29</xref>, <xref ref-type="bibr" rid="CR30">30</xref>], but also as additional factors of complexity, as they represent also major risk factors to various other LTCs [<xref ref-type="bibr" rid="CR31">31</xref>] including traumatic injuries [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>], HIV/AIDS [<xref ref-type="bibr" rid="CR34">34</xref>], hepatitis C [<xref ref-type="bibr" rid="CR35">35</xref>], mental health conditions [<xref ref-type="bibr" rid="CR36">36</xref>] and cardiovascular diseases [<xref ref-type="bibr" rid="CR37">37</xref>].</p><p id="Par46">In turn, these behavioural/lifestyle aspects sheds further light on the specific patterns of multimorbidity observed in associated clusters, notably the higher prevalence of HIV/AIDS, viral hepatitis and serious mental illness in cluster 1, and depression and anxiety disorder in cluster 5. Likewise, the higher prevalence of chronic pain observed in cluster 5 and 6 can be apprehended as a factor of complexity associated with depression, anxiety disorders and morbid obesity [<xref ref-type="bibr" rid="CR38">38</xref>] in cluster 5 and osteoarthritis [<xref ref-type="bibr" rid="CR39">39</xref>] in cluster 6.</p><p id="Par47">Of note, dementia, prevalent in clusters 2, 3 and 6, is a condition marked by significant cognitive and functional impairments [<xref ref-type="bibr" rid="CR40">40</xref>] (i.e. a high burden of illness). This condition is also recognized as a major causes of dependency post-stroke [<xref ref-type="bibr" rid="CR41">41</xref>]. Dependency, however, refers implicitly to a patient&#8217;s relational network and its ability to interact with the healthcare system in order to cope with the patient&#8217;s workload [<xref ref-type="bibr" rid="CR25">25</xref>] which prevents further patient complexity. This ability to engage one&#8217;s social network, which also depends on the patient&#8217;s socioeconomic environment, should be borne in mind when interpreting the higher prevalence of LTCs associated with both high levels of illness and treatment, such as dementia or cancer (clusters 1-3).</p></sec><sec id="Sec13"><title>Conventional stroke risk factors, age and ethnicity (clusters 2 to 4)</title><p id="Par48">Clusters 2 to 4 form the core clusters within the typology, accounting for over half of analysed patients. Notably these clusters are characterized by a higher prevalence of conventional stroke risk factors. The opposite trends observed from clusters 2 to 4 in the median age at record of stroke and the prevalence of hypertension, diabetes, and hypercholesterolaemia, in parallel with higher representation of patients from Asian, Black, and mixed ethnicity is a marking trait of the typology (Tables <xref rid="Tab2" ref-type="table">2</xref> and <xref rid="Tab3" ref-type="table">3</xref>, and Figs. <xref rid="Fig2" ref-type="fig">2</xref>, <xref rid="Fig3" ref-type="fig">3</xref> and S4). These trends highlight the importance of these conventional stroke risk factors in a lifespan, earlier records of stroke being observed in clusters characterised by earlier records, and higher prevalence of these conventional stroke risk factors. Of note, the parallel increase in the proportion of patients from non-White ethnicity in these clusters not only suggests an ethnic susceptibility to these risk factors, but also an ethnic vulnerability to stoke given these risk factors [<xref ref-type="bibr" rid="CR42">42</xref>]. Importantly, this highlights also the opportunity for age and culturally tailored lifestyle interventions for the prevention and management of these conventional stroke risk factors [<xref ref-type="bibr" rid="CR43">43</xref>].</p></sec><sec id="Sec14"><title>Low levels of multimorbidity (clusters 7 and 8)</title><p id="Par49">Sickle cell anaemia, characterising cluster 7, is the most common and severe form of sickle cell disease and is particularly prevalent in people of African, Middle Eastern and Indian descent [<xref ref-type="bibr" rid="CR44">44</xref>]. Despite available strategies to prevent (and manage) stroke in sickle cell anaemia patients [<xref ref-type="bibr" rid="CR45">45</xref>], its appearance as a marking trait of cluster 7 highlights its significance as a stroke risk factor in younger patients [<xref ref-type="bibr" rid="CR46">46</xref>]. A low level of multimorbidity is also a characteristic of clusters 7 and 8.</p></sec></sec><sec id="Sec15"><title>Conclusion</title><p id="Par50">This study has adopted an unsupervised patient-oriented clustering approach to analyse longitudinal primary care EHRs of 30 LTCs to identify patterns of multimorbidity associated with stroke in a relatively large cohort of 9,847 patients. A typology of eight clusters of health trajectories characterised by distinct patterns of multimorbidity, levels of medication, socio-demographics profiles, and stroke risk factors was derived. Identified clusters reflect marked trends in age, ethnicity and prevalence of conventional stroke risk factors, and highlight the importance of mental health conditions in conjunction with behavioural/lifestyle related factors in complex profiles of multimorbidity displayed in a significant proportion of patients. The typology reveals also specific combinations, such as osteoarthritis and chronic pain in older patients, sickle cell anaemia or low levels of multimorbidity and risk factors in younger patients.</p><p id="Par51">These results align with previous finding on stroke associated multimorbidity [<xref ref-type="bibr" rid="CR1">1</xref>&#8211;<xref ref-type="bibr" rid="CR3">3</xref>] and more generally with the epidemiology of stroke which is more likely to occur in older male patients with a background of hypertension and/or diabetes [<xref ref-type="bibr" rid="CR47">47</xref>], these risk factors being more prevalent in patients from Asian and Black ethnicity [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Other key points include, the association between mental health conditions and infectious diseases [<xref ref-type="bibr" rid="CR34">34</xref>], the correlation between the number of long-term conditions and the number of medication [<xref ref-type="bibr" rid="CR50">50</xref>], and specific long-term conditions such as asthma and mental health conditions, osteoarthritis or sickle-cell anaemia as landmark of the different identified patterns.</p><p id="Par52">While, mental health conditions are considered as non-traditional stroke risk factor [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR51">51</xref>, <xref ref-type="bibr" rid="CR52">52</xref>], the association between stoke and osteoarthritis or asthma is more controversial. Proposed explanations include the shared risk factors hypothesis (older age (cluster 6) or obesity and smoking habits (cluster 5) [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR54">54</xref>]), the activation of inflammatory pathophysiological pathways, that contribute to vascular inflammation and atherosclerosis observed in stroke [<xref ref-type="bibr" rid="CR55">55</xref>], and the exposure to non-steroidal anti-inflammatory drugs used for managing osteoarthritis symptoms [<xref ref-type="bibr" rid="CR56">56</xref>] or <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\beta$$\end{document}</tex-math><mml:math id="M2"><mml:mi>&#946;</mml:mi></mml:math><inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12875_2024_2636_Article_IEq1.gif"/></alternatives></inline-formula>2-agonists and systemic corticosteroids used in asthma treatment [<xref ref-type="bibr" rid="CR57">57</xref>&#8211;<xref ref-type="bibr" rid="CR59">59</xref>]. Stroke is also considered as a catastrophic complication of sickle-cell anaemia [<xref ref-type="bibr" rid="CR46">46</xref>], occurring in 5% to 10% of patients before adulthood, and up to 24% by the age of 45 [<xref ref-type="bibr" rid="CR60">60</xref>]. Finally, the low level of multimorbidity and the absence of combination of major risk factors in cluster 8 are also remarkable results of the proposed typology. This trend reflects the lower prevalence of multimorbidity observed in younger patients [<xref ref-type="bibr" rid="CR61">61</xref>], or possibly cryptogenic strokes [<xref ref-type="bibr" rid="CR62">62</xref>] and insufficient screening strategies of cardiovascular risk factors in this younger population [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par53">These results exemplify the ability of the proposed method to identify specific patterns of multimorbidity or even repeated motives displayed in various subpopulations. For instance the sequences osteoarthritis to stroke which involves more that 90% of patients in cluster 6 (Table <xref rid="Tab4" ref-type="table">4</xref>) and sickle-cell anaemia to stroke observed in 87.8% of patients diagnosed with sickle-cell anaemia in cluster 7, or the sequence hypertension/stroke spotted at different ages and socio-demographic contexts from cluster 2 to cluster 3 with a shift of about 25 years between cluster 2 and 4 and 15 years between cluster 2 and 3.</p><p id="Par54">Multimorbidity is known to have profound implications for both patients and primary care [<xref ref-type="bibr" rid="CR64">64</xref>]. However, beyond the necessity of measuring the prevalence of multimorbidity, the identification of recurrent patterns of long-term conditions is needed to effectively promote patient oriented prevention and care strategies tailored to the needs of the main patient groups [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. Accordingly, our results suggest that initiatives such as age and culturally tailored lifestyle interventions to prevent and manage conventional stroke risk factors [<xref ref-type="bibr" rid="CR43">43</xref>], as well as evaluations of patient complexity and associated needs [<xref ref-type="bibr" rid="CR1">1</xref>], could be beneficial to both patients and primary care professionals in the considered areas.</p><p id="Par55">Although our study aims to address previously identified methodological and evidence gaps in the longitudinal mapping of long-term conditions into distinct patterns of multimorbidity associated with stroke [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR28">28</xref>], our results are subject to limitations. These limitations arise from factors including the specific environment and population characteristics (urban, young, multi-ethnic, and deprived) as well as methodological choices, such as the use of&#160;a specific metrics to compute patient distances and the subsequent selection of clustering methods. Further research should be conducted in collaboration with patients, primary care professionals, and higher education institutions, including primary care teachers and trainees. This collaborative approach will enhance study designs to better align with patients&#8217; needs and develop strategies to more effectively translate epidemiological evidence into practice.</p></sec><sec id="Sec16" sec-type="supplementary-material"><title>Supplementary Information</title><p>
<supplementary-material content-type="local-data" id="MOESM1" position="float" orientation="portrait"><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12875_2024_2636_MOESM1_ESM.pdf" position="float" orientation="portrait"><caption><p>Supplementary Material 1.</p></caption></media></supplementary-material></p></sec></body><back><glossary><title>Abbreviations</title><def-list><def-item><term>EHR</term><def><p id="Par5">Electronic health records</p></def></def-item><def-item><term>LTC</term><def><p id="Par6">Long-term conditions</p></def></def-item><def-item><term>CKD</term><def><p id="Par7">Chronic kidney disease</p></def></def-item><def-item><term>COPD</term><def><p id="Par8">Chronic obstructive pulmonary disease</p></def></def-item><def-item><term>IMD</term><def><p id="Par9">Index of multiple deprivation</p></def></def-item><def-item><term>NHI</term><def><p id="Par10">National health institute</p></def></def-item></def-list></glossary><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We are grateful to Professor Anne Stephenson, Dr. Niki Jakeways, and Dr. Rini Paul from King&#8217;s Undergraduate Medical Education in the Community for their support with this project.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>AD and MD designed the study (conceptualization and methodology), AD, MA, XS and MD conducted investigations, XS, AL and MD carried out data curation, MD provided computer code and performed formal analysis including data visualisation and validation, MD drafted the manuscript, and AD supervised the research. MA, AD, VC, XS, and CW reviewed and edited the manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This project is funded by King&#8217;s Health Partners / Guy&#8217;s and St Thomas Charity &#8216;MLTC Challenge Fund&#8217; (grant number EIC180702) and support from the National Institute for Health and Care Research (NIHR) under its Programme Grants for Applied Research (NIHR202339).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>Restrictions apply to the availability of the data supporting the findings of this study. The data were used under license, following project approval by the Lambeth Clinical Commissioning Group, and therefore are not publicly available.</p></notes><notes><title>Declarations</title><notes id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par56">This study was conducted in accordance with the Declaration of Helsinki. Data were provided by the Lambeth DataNet upon approval for the analysis of fully anonymised data by the Lambeth Clinical Commissioning Group. All patients were informed through &#8217;Fair Processing Notices&#8217; of the potential use of collected electronic health records in &#8217;secondary data analysis&#8217; and were given the option to opt out of data sharing scheme. Accordingly, this study was exempt from ethical committee approval and individual consent requirements as per the National Health Institute (NHI) Health Research Authority (HRA) guidelines for research using anonymised primary care data in the United Kingdom.</p></notes><notes id="FPar2"><title>Consent for publication</title><p id="Par57">Not applicable.</p></notes><notes id="FPar3" notes-type="COI-statement"><title>Competing interests</title><p id="Par58">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallacher</surname><given-names>KI</given-names></name><name name-style="western"><surname>Batty</surname><given-names>GD</given-names></name><name name-style="western"><surname>McLean</surname><given-names>G</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>SW</given-names></name><name name-style="western"><surname>Guthrie</surname><given-names>B</given-names></name><name name-style="western"><surname>May</surname><given-names>CR</given-names></name><name name-style="western"><surname>Langhorne</surname><given-names>P</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name></person-group><article-title>Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in scotland: implications for treatment burden</article-title><source>BMC Med.</source><year>2014</year><volume>12</volume><issue>1</issue><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s12916-014-0151-0</pub-id><pub-id pub-id-type="pmcid">PMC4220053</pub-id><pub-id pub-id-type="pmid">25280748</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Gallacher KI, Batty GD, McLean G, Mercer SW, Guthrie B, May CR, Langhorne P, Mair FS. Stroke, multimorbidity and polypharmacy in a nationally representative sample of 1,424,378 patients in scotland: implications for treatment burden. BMC Med. 2014;12(1):1&#8211;9.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12916-014-0151-0</pub-id><pub-id pub-id-type="pmcid">PMC4220053</pub-id><pub-id pub-id-type="pmid">25280748</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallacher</surname><given-names>KI</given-names></name><name name-style="western"><surname>McQueenie</surname><given-names>R</given-names></name><name name-style="western"><surname>Nicholl</surname><given-names>B</given-names></name><name name-style="western"><surname>Jani</surname><given-names>BD</given-names></name><name name-style="western"><surname>Lee</surname><given-names>D</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name></person-group><article-title>Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 uk biobank participants</article-title><source>J Comorbidity</source><year>2018</year><volume>8</volume><issue>1</issue><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="doi">10.15256/joc.2018.8.129</pub-id><pub-id pub-id-type="pmcid">PMC5827474</pub-id><pub-id pub-id-type="pmid">29492397</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Gallacher KI, McQueenie R, Nicholl B, Jani BD, Lee D, Mair FS. Risk factors and mortality associated with multimorbidity in people with stroke or transient ischaemic attack: a study of 8,751 uk biobank participants. J Comorbidity. 2018;8(1):1&#8211;8.<pub-id pub-id-type="doi" assigning-authority="pmc">10.15256/joc.2018.8.129</pub-id><pub-id pub-id-type="pmcid">PMC5827474</pub-id><pub-id pub-id-type="pmid">29492397</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallacher</surname><given-names>KI</given-names></name><name name-style="western"><surname>Jani</surname><given-names>BD</given-names></name><name name-style="western"><surname>Hanlon</surname><given-names>P</given-names></name><name name-style="western"><surname>Nicholl</surname><given-names>BI</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name></person-group><article-title>Multimorbidity in stroke</article-title><source>Stroke.</source><year>2019</year><volume>50</volume><issue>7</issue><fpage>1919</fpage><lpage>1926</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.118.020376</pub-id><pub-id pub-id-type="pmid">31233391</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Gallacher KI, Jani BD, Hanlon P, Nicholl BI, Mair FS. Multimorbidity in stroke. Stroke. 2019;50(7):1919&#8211;26.<pub-id pub-id-type="pmid">31233391</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.118.020376</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="other">The&#160;Academy of&#160;Medical&#160;Sciences. Multiple long-term conditions (multimorbidity): a priority for global health research. 2023. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://acmedsci.ac.uk/file-download/82222577">https://acmedsci.ac.uk/file-download/82222577</ext-link>. Accessed 28 Jul 2023.</mixed-citation></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Johnston</surname><given-names>MC</given-names></name><name name-style="western"><surname>Crilly</surname><given-names>M</given-names></name><name name-style="western"><surname>Black</surname><given-names>C</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>GJ</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>SW</given-names></name></person-group><article-title>Defining and measuring multimorbidity: a systematic review of systematic reviews</article-title><source>Eur J Public Health.</source><year>2019</year><volume>29</volume><issue>1</issue><fpage>182</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1093/eurpub/cky098</pub-id><pub-id pub-id-type="pmid">29878097</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Johnston MC, Crilly M, Black C, Prescott GJ, Mercer SW. Defining and measuring multimorbidity: a systematic review of systematic reviews. Eur J Public Health. 2019;29(1):182&#8211;9.<pub-id pub-id-type="pmid">29878097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/eurpub/cky098</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Skou</surname><given-names>ST</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name><name name-style="western"><surname>Fortin</surname><given-names>M</given-names></name><name name-style="western"><surname>Guthrie</surname><given-names>B</given-names></name><name name-style="western"><surname>Nunes</surname><given-names>BP</given-names></name><name name-style="western"><surname>Miranda</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Boyd</surname><given-names>CM</given-names></name><name name-style="western"><surname>Pati</surname><given-names>S</given-names></name><name name-style="western"><surname>Mtenga</surname><given-names>S</given-names></name><name name-style="western"><surname>Smith</surname><given-names>SM</given-names></name></person-group><article-title>Multimorbidity</article-title><source>Nat Rev Dis Prim.</source><year>2022</year><volume>8</volume><issue>1</issue><fpage>48</fpage><pub-id pub-id-type="doi">10.1038/s41572-022-00376-4</pub-id><pub-id pub-id-type="pmid">35835758</pub-id><pub-id pub-id-type="pmcid">PMC7613517</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Skou ST, Mair FS, Fortin M, Guthrie B, Nunes BP, Miranda JJ, Boyd CM, Pati S, Mtenga S, Smith SM. Multimorbidity. Nat Rev Dis Prim. 2022;8(1):48.<pub-id pub-id-type="pmid">35835758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41572-022-00376-4</pub-id><pub-id pub-id-type="pmcid">PMC7613517</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fortin</surname><given-names>M</given-names></name><name name-style="western"><surname>Stewart</surname><given-names>M</given-names></name><name name-style="western"><surname>Poitras</surname><given-names>M-E</given-names></name><name name-style="western"><surname>Almirall</surname><given-names>J</given-names></name><name name-style="western"><surname>Maddocks</surname><given-names>H</given-names></name></person-group><article-title>A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology</article-title><source>Ann Fam Med.</source><year>2012</year><volume>10</volume><issue>2</issue><fpage>142</fpage><lpage>151</lpage><pub-id pub-id-type="doi">10.1370/afm.1337</pub-id><pub-id pub-id-type="pmid">22412006</pub-id><pub-id pub-id-type="pmcid">PMC3315131</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Fortin M, Stewart M, Poitras M-E, Almirall J, Maddocks H. A systematic review of prevalence studies on multimorbidity: toward a more uniform methodology. Ann Fam Med. 2012;10(2):142&#8211;51.<pub-id pub-id-type="pmid">22412006</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1370/afm.1337</pub-id><pub-id pub-id-type="pmcid">PMC3315131</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>M</given-names></name><name name-style="western"><surname>Jacobsen</surname><given-names>JB</given-names></name><name name-style="western"><surname>Johnsen</surname><given-names>SP</given-names></name><name name-style="western"><surname>B&#248;tker</surname><given-names>HE</given-names></name><name name-style="western"><surname>S&#248;rensen</surname><given-names>HT</given-names></name></person-group><article-title>Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity</article-title><source>Neurology.</source><year>2014</year><volume>82</volume><issue>4</issue><fpage>340</fpage><lpage>350</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000000062</pub-id><pub-id pub-id-type="pmid">24363134</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Schmidt M, Jacobsen JB, Johnsen SP, B&#248;tker HE, S&#248;rensen HT. Eighteen-year trends in stroke mortality and the prognostic influence of comorbidity. Neurology. 2014;82(4):340&#8211;50.<pub-id pub-id-type="pmid">24363134</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000000062</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Safford</surname><given-names>MM</given-names></name><name name-style="western"><surname>Allison</surname><given-names>JJ</given-names></name><name name-style="western"><surname>Kiefe</surname><given-names>CI</given-names></name></person-group><article-title>Patient complexity: more than comorbidity. The vector model of complexity</article-title><source>J Gen Intern Med.</source><year>2007</year><volume>22</volume><fpage>382</fpage><lpage>390</lpage><pub-id pub-id-type="doi">10.1007/s11606-007-0307-0</pub-id><pub-id pub-id-type="pmid">18026806</pub-id><pub-id pub-id-type="pmcid">PMC2219701</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Safford MM, Allison JJ, Kiefe CI. Patient complexity: more than comorbidity. The vector model of complexity. J Gen Intern Med. 2007;22:382&#8211;90.<pub-id pub-id-type="pmid">18026806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11606-007-0307-0</pub-id><pub-id pub-id-type="pmcid">PMC2219701</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Chin</surname><given-names>SL</given-names></name><name name-style="western"><surname>Rao-Melacini</surname><given-names>P</given-names></name><name name-style="western"><surname>Rangarajan</surname><given-names>S</given-names></name><name name-style="western"><surname>Islam</surname><given-names>S</given-names></name><name name-style="western"><surname>Pais</surname><given-names>P</given-names></name><name name-style="western"><surname>McQueen</surname><given-names>MJ</given-names></name><etal/></person-group><article-title>Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study</article-title><source>Lancet.</source><year>2010</year><volume>376</volume><issue>9735</issue><fpage>112</fpage><lpage>123</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)60834-3</pub-id><pub-id pub-id-type="pmid">20561675</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">O&#8217;Donnell MJ, Xavier D, Liu L, Zhang H, Chin SL, Rao-Melacini P, Rangarajan S, Islam S, Pais P, McQueen MJ, et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the interstroke study): a case-control study. Lancet. 2010;376(9735):112&#8211;23.<pub-id pub-id-type="pmid">20561675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(10)60834-3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bang</surname><given-names>OY</given-names></name><name name-style="western"><surname>Ovbiagele</surname><given-names>B</given-names></name><name name-style="western"><surname>Kim</surname><given-names>JS</given-names></name></person-group><article-title>Nontraditional risk factors for ischemic stroke: an update</article-title><source>Stroke.</source><year>2015</year><volume>46</volume><issue>12</issue><fpage>3571</fpage><lpage>3578</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.115.010954</pub-id><pub-id pub-id-type="pmid">26514189</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Bang OY, Ovbiagele B, Kim JS. Nontraditional risk factors for ischemic stroke: an update. Stroke. 2015;46(12):3571&#8211;8.<pub-id pub-id-type="pmid">26514189</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.115.010954</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gruneir</surname><given-names>A</given-names></name><name name-style="western"><surname>Griffith</surname><given-names>LE</given-names></name><name name-style="western"><surname>Fisher</surname><given-names>K</given-names></name><name name-style="western"><surname>Panjwani</surname><given-names>D</given-names></name><name name-style="western"><surname>Gandhi</surname><given-names>S</given-names></name><name name-style="western"><surname>Sheng</surname><given-names>L</given-names></name><name name-style="western"><surname>Patterson</surname><given-names>C</given-names></name><name name-style="western"><surname>Gafni</surname><given-names>A</given-names></name><name name-style="western"><surname>Ploeg</surname><given-names>J</given-names></name><name name-style="western"><surname>Markle-Reid</surname><given-names>M</given-names></name></person-group><article-title>Increasing comorbidity and health services utilization in older adults with prior stroke</article-title><source>Neurology.</source><year>2016</year><volume>87</volume><issue>20</issue><fpage>2091</fpage><lpage>2098</lpage><pub-id pub-id-type="doi">10.1212/WNL.0000000000003329</pub-id><pub-id pub-id-type="pmid">27760870</pub-id><pub-id pub-id-type="pmcid">PMC5109944</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Gruneir A, Griffith LE, Fisher K, Panjwani D, Gandhi S, Sheng L, Patterson C, Gafni A, Ploeg J, Markle-Reid M. Increasing comorbidity and health services utilization in older adults with prior stroke. Neurology. 2016;87(20):2091&#8211;8.<pub-id pub-id-type="pmid">27760870</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1212/WNL.0000000000003329</pub-id><pub-id pub-id-type="pmcid">PMC5109944</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Aquino</surname><given-names>MRJRV</given-names></name><name name-style="western"><surname>Turner</surname><given-names>GM</given-names></name><name name-style="western"><surname>Mant</surname><given-names>J</given-names></name></person-group><article-title>Does characterising patterns of multimorbidity in stroke matter for developing collaborative care approaches in primary care?</article-title><source>Primary Health Care Res Dev.</source><year>2019</year><volume>20</volume><fpage>e110</fpage><pub-id pub-id-type="doi">10.1017/S1463423619000240</pub-id><pub-id pub-id-type="pmcid">PMC6635803</pub-id><pub-id pub-id-type="pmid">32800014</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Aquino MRJRV, Turner GM, Mant J. Does characterising patterns of multimorbidity in stroke matter for developing collaborative care approaches in primary care? Primary Health Care Res Dev. 2019;20:e110.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1463423619000240</pub-id><pub-id pub-id-type="pmcid">PMC6635803</pub-id><pub-id pub-id-type="pmid">32800014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cezard</surname><given-names>G</given-names></name><name name-style="western"><surname>McHale</surname><given-names>CT</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>F</given-names></name><name name-style="western"><surname>Bowles</surname><given-names>JKF</given-names></name><name name-style="western"><surname>Keenan</surname><given-names>K</given-names></name></person-group><article-title>Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence</article-title><source>BMJ Open.</source><year>2021</year><volume>11</volume><issue>11</issue><fpage>e048485</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2020-048485</pub-id><pub-id pub-id-type="pmid">34810182</pub-id><pub-id pub-id-type="pmcid">PMC8609933</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Cezard G, McHale CT, Sullivan F, Bowles JKF, Keenan K. Studying trajectories of multimorbidity: a systematic scoping review of longitudinal approaches and evidence. BMJ Open. 2021;11(11):e048485.<pub-id pub-id-type="pmid">34810182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2020-048485</pub-id><pub-id pub-id-type="pmcid">PMC8609933</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Elder</surname><given-names>GH</given-names><suffix>Jr</suffix></name></person-group><article-title>The life course as developmental theory</article-title><source>Child Dev.</source><year>1998</year><volume>69</volume><issue>1</issue><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1111/j.1467-8624.1998.tb06128.x</pub-id><pub-id pub-id-type="pmid">9499552</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Elder GH Jr. The life course as developmental theory. Child Dev. 1998;69(1):1&#8211;12.<pub-id pub-id-type="pmid">9499552</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Kaufman</surname><given-names>L</given-names></name><name name-style="western"><surname>Rousseeuw</surname><given-names>PJ</given-names></name></person-group><source>Finding Groups in Data: An Introduction to Cluster Analysis</source><year>2009</year><edition>1</edition><publisher-loc>Hoboken</publisher-loc><publisher-name>Wiley</publisher-name></element-citation><mixed-citation id="mc-CR16" publication-type="book">Kaufman L, Rousseeuw PJ. Finding Groups in Data: An Introduction to Cluster Analysis. 1st ed. Hoboken: Wiley; 2009.</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ng</surname><given-names>SK</given-names></name><name name-style="western"><surname>Tawiah</surname><given-names>R</given-names></name><name name-style="western"><surname>Sawyer</surname><given-names>M</given-names></name><name name-style="western"><surname>Scuffham</surname><given-names>P</given-names></name></person-group><article-title>Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis</article-title><source>Int J Epidemiol.</source><year>2018</year><volume>47</volume><issue>5</issue><fpage>1687</fpage><lpage>1704</lpage><pub-id pub-id-type="doi">10.1093/ije/dyy134</pub-id><pub-id pub-id-type="pmid">30016472</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Ng SK, Tawiah R, Sawyer M, Scuffham P. Patterns of multimorbid health conditions: a systematic review of analytical methods and comparison analysis. Int J Epidemiol. 2018;47(5):1687&#8211;704.<pub-id pub-id-type="pmid">30016472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ije/dyy134</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pollock</surname><given-names>G</given-names></name></person-group><article-title>Holistic trajectories: a study of combined employment, housing and family careers by using multiple-sequence analysis</article-title><source>J R Stat Soc Ser A (Stat Soc).</source><year>2007</year><volume>170</volume><issue>1</issue><fpage>167</fpage><lpage>183</lpage><pub-id pub-id-type="doi">10.1111/j.1467-985X.2006.00450.x</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Pollock G. Holistic trajectories: a study of combined employment, housing and family careers by using multiple-sequence analysis. J R Stat Soc Ser A (Stat Soc). 2007;170(1):167&#8211;83.</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shippee</surname><given-names>ND</given-names></name><name name-style="western"><surname>Shah</surname><given-names>ND</given-names></name><name name-style="western"><surname>May</surname><given-names>CR</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name><name name-style="western"><surname>Montori</surname><given-names>VM</given-names></name></person-group><article-title>Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice</article-title><source>J Clin Epidemiol.</source><year>2012</year><volume>65</volume><issue>10</issue><fpage>1041</fpage><lpage>1051</lpage><pub-id pub-id-type="doi">10.1016/j.jclinepi.2012.05.005</pub-id><pub-id pub-id-type="pmid">22910536</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Shippee ND, Shah ND, May CR, Mair FS, Montori VM. Cumulative complexity: a functional, patient-centered model of patient complexity can improve research and practice. J Clin Epidemiol. 2012;65(10):1041&#8211;51.<pub-id pub-id-type="pmid">22910536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinepi.2012.05.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hafezparast</surname><given-names>N</given-names></name><name name-style="western"><surname>Turner</surname><given-names>EB</given-names></name><name name-style="western"><surname>Dunbar-Rees</surname><given-names>R</given-names></name><name name-style="western"><surname>Vodden</surname><given-names>A</given-names></name><name name-style="western"><surname>Dodhia</surname><given-names>H</given-names></name><name name-style="western"><surname>Reynolds</surname><given-names>B</given-names></name><name name-style="western"><surname>Reichwein</surname><given-names>B</given-names></name><name name-style="western"><surname>Ashworth</surname><given-names>M</given-names></name></person-group><article-title>Adapting the definition of multimorbidity-development of a locality-based consensus for selecting included long term conditions</article-title><source>BMC Fam Pract.</source><year>2021</year><volume>22</volume><issue>1</issue><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/s12875-021-01477-x</pub-id><pub-id pub-id-type="pmid">34162331</pub-id><pub-id pub-id-type="pmcid">PMC8223362</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Hafezparast N, Turner EB, Dunbar-Rees R, Vodden A, Dodhia H, Reynolds B, Reichwein B, Ashworth M. Adapting the definition of multimorbidity-development of a locality-based consensus for selecting included long term conditions. BMC Fam Pract. 2021;22(1):1&#8211;11.<pub-id pub-id-type="pmid">34162331</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12875-021-01477-x</pub-id><pub-id pub-id-type="pmcid">PMC8223362</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Milligan</surname><given-names>GW</given-names></name><name name-style="western"><surname>Cooper</surname><given-names>MC</given-names></name></person-group><article-title>An examination of procedures for determining the number of clusters in a data set</article-title><source>Psychometrika.</source><year>1985</year><volume>50</volume><fpage>159</fpage><lpage>179</lpage><pub-id pub-id-type="doi">10.1007/BF02294245</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Milligan GW, Cooper MC. An examination of procedures for determining the number of clusters in a data set. Psychometrika. 1985;50:159&#8211;79.</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="other">Delord M, Douiri A. Unsupervised clustering approach to multiple time-to-event electronic health records applied to multimorbidity associated with myocardial infarction. 2023 Jul 12 [Preprint]. Research Square. Available from: 10.21203/rs.3.rs-3127943/v1.</mixed-citation></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Jaccard</surname><given-names>P</given-names></name></person-group><article-title>&#201;tude comparative de la distribution florale dans une portion des alpes et des jura</article-title><source>Bull Soc Vaudoise Sci Nat.</source><year>1901</year><volume>37</volume><fpage>547</fpage><lpage>579</lpage></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Jaccard P. &#201;tude comparative de la distribution florale dans une portion des alpes et des jura. Bull Soc Vaudoise Sci Nat. 1901;37:547&#8211;79.</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="other">R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2023.</mixed-citation></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>May</surname><given-names>CR</given-names></name><name name-style="western"><surname>Eton</surname><given-names>DT</given-names></name><name name-style="western"><surname>Boehmer</surname><given-names>K</given-names></name><name name-style="western"><surname>Gallacher</surname><given-names>K</given-names></name><name name-style="western"><surname>Hunt</surname><given-names>K</given-names></name><name name-style="western"><surname>MacDonald</surname><given-names>S</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name><name name-style="western"><surname>May</surname><given-names>CM</given-names></name><name name-style="western"><surname>Montori</surname><given-names>VM</given-names></name><name name-style="western"><surname>Richardson</surname><given-names>A</given-names></name><etal/></person-group><article-title>Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness</article-title><source>BMC Health Serv Res.</source><year>2014</year><volume>14</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1186/1472-6963-14-281</pub-id><pub-id pub-id-type="pmid">24969758</pub-id><pub-id pub-id-type="pmcid">PMC4080515</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">May CR, Eton DT, Boehmer K, Gallacher K, Hunt K, MacDonald S, Mair FS, May CM, Montori VM, Richardson A, et al. Rethinking the patient: using burden of treatment theory to understand the changing dynamics of illness. BMC Health Serv Res. 2014;14:1&#8211;11.<pub-id pub-id-type="pmid">24969758</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/1472-6963-14-281</pub-id><pub-id pub-id-type="pmcid">PMC4080515</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Centers for Disease Control and Prevention (CDC). Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation&#8211;United States, 2010-2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):869&#8211;73<pub-id pub-id-type="pmcid">PMC4585589</pub-id><pub-id pub-id-type="pmid">24196662</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moussavi</surname><given-names>S</given-names></name><name name-style="western"><surname>Chatterji</surname><given-names>S</given-names></name><name name-style="western"><surname>Verdes</surname><given-names>E</given-names></name><name name-style="western"><surname>Tandon</surname><given-names>A</given-names></name><name name-style="western"><surname>Patel</surname><given-names>V</given-names></name><name name-style="western"><surname>Ustun</surname><given-names>B</given-names></name></person-group><article-title>Depression, chronic diseases, and decrements in health: results from the world health surveys</article-title><source>Lancet.</source><year>2007</year><volume>370</volume><issue>9590</issue><fpage>851</fpage><lpage>858</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(07)61415-9</pub-id><pub-id pub-id-type="pmid">17826170</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the world health surveys. Lancet. 2007;370(9590):851&#8211;8.<pub-id pub-id-type="pmid">17826170</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(07)61415-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallacher</surname><given-names>KI</given-names></name><name name-style="western"><surname>May</surname><given-names>CR</given-names></name><name name-style="western"><surname>Langhorne</surname><given-names>P</given-names></name><name name-style="western"><surname>Mair</surname><given-names>FS</given-names></name></person-group><article-title>A conceptual model of treatment burden and patient capacity in stroke</article-title><source>BMC Fam Pract.</source><year>2018</year><volume>19</volume><fpage>1</fpage><lpage>15</lpage><pub-id pub-id-type="doi">10.1186/s12875-017-0691-4</pub-id><pub-id pub-id-type="pmid">29316892</pub-id><pub-id pub-id-type="pmcid">PMC5759246</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Gallacher KI, May CR, Langhorne P, Mair FS. A conceptual model of treatment burden and patient capacity in stroke. BMC Fam Pract. 2018;19:1&#8211;15.<pub-id pub-id-type="pmid">29316892</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12875-017-0691-4</pub-id><pub-id pub-id-type="pmcid">PMC5759246</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>De Los</surname><given-names>R&#237;os F</given-names></name><name name-style="western"><surname>Kleindorfer</surname><given-names>DO</given-names></name><name name-style="western"><surname>Khoury</surname><given-names>J</given-names></name><name name-style="western"><surname>Broderick</surname><given-names>JP</given-names></name><name name-style="western"><surname>Moomaw</surname><given-names>CJ</given-names></name><name name-style="western"><surname>Adeoye</surname><given-names>O</given-names></name><name name-style="western"><surname>Flaherty</surname><given-names>ML</given-names></name><name name-style="western"><surname>Khatri</surname><given-names>P</given-names></name><name name-style="western"><surname>Woo</surname><given-names>D</given-names></name><name name-style="western"><surname>Alwell</surname><given-names>K</given-names></name><etal/></person-group><article-title>Trends in substance abuse preceding stroke among young adults: a population-based study</article-title><source>Stroke.</source><year>2012</year><volume>43</volume><issue>12</issue><fpage>3179</fpage><lpage>3183</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.112.667808</pub-id><pub-id pub-id-type="pmid">23160887</pub-id><pub-id pub-id-type="pmcid">PMC3742309</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">De Los R&#237;os F, Kleindorfer DO, Khoury J, Broderick JP, Moomaw CJ, Adeoye O, Flaherty ML, Khatri P, Woo D, Alwell K, et al. Trends in substance abuse preceding stroke among young adults: a population-based study. Stroke. 2012;43(12):3179&#8211;83.<pub-id pub-id-type="pmid">23160887</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.112.667808</pub-id><pub-id pub-id-type="pmcid">PMC3742309</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Chin</surname><given-names>SL</given-names></name><name name-style="western"><surname>Rangarajan</surname><given-names>S</given-names></name><name name-style="western"><surname>Xavier</surname><given-names>D</given-names></name><name name-style="western"><surname>Liu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>H</given-names></name><name name-style="western"><surname>Rao-Melacini</surname><given-names>P</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Pais</surname><given-names>P</given-names></name><name name-style="western"><surname>Agapay</surname><given-names>S</given-names></name><etal/></person-group><article-title>Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (interstroke): a case-control study</article-title><source>Lancet.</source><year>2016</year><volume>388</volume><issue>10046</issue><fpage>761</fpage><lpage>775</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(16)30506-2</pub-id><pub-id pub-id-type="pmid">27431356</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">O&#8217;Donnell MJ, Chin SL, Rangarajan S, Xavier D, Liu L, Zhang H, Rao-Melacini P, Zhang X, Pais P, Agapay S, et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (interstroke): a case-control study. Lancet. 2016;388(10046):761&#8211;75.<pub-id pub-id-type="pmid">27431356</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(16)30506-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mertens</surname><given-names>JR</given-names></name><name name-style="western"><surname>Weisner</surname><given-names>C</given-names></name><name name-style="western"><surname>Ray</surname><given-names>GT</given-names></name><name name-style="western"><surname>Fireman</surname><given-names>B</given-names></name><name name-style="western"><surname>Walsh</surname><given-names>K</given-names></name></person-group><article-title>Hazardous drinkers and drug users in hmo primary care: prevalence, medical conditions, and costs</article-title><source>Alcohol Clin Exp Res.</source><year>2005</year><volume>29</volume><issue>6</issue><fpage>989</fpage><lpage>998</lpage><pub-id pub-id-type="doi">10.1097/01.ALC.0000167958.68586.3D</pub-id><pub-id pub-id-type="pmid">15976525</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Mertens JR, Weisner C, Ray GT, Fireman B, Walsh K. Hazardous drinkers and drug users in hmo primary care: prevalence, medical conditions, and costs. Alcohol Clin Exp Res. 2005;29(6):989&#8211;98.<pub-id pub-id-type="pmid">15976525</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/01.alc.0000167958.68586.3d</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherpitel</surname><given-names>CJ</given-names></name></person-group><article-title>Alcohol and injuries: a review of international emergency room studies since 1995</article-title><source>Drug Alcohol Rev.</source><year>2007</year><volume>26</volume><issue>2</issue><fpage>201</fpage><lpage>214</lpage><pub-id pub-id-type="doi">10.1080/09595230601146686</pub-id><pub-id pub-id-type="pmid">17364856</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Cherpitel CJ. Alcohol and injuries: a review of international emergency room studies since 1995. Drug Alcohol Rev. 2007;26(2):201&#8211;14.<pub-id pub-id-type="pmid">17364856</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/09595230601146686</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cheng</surname><given-names>V</given-names></name><name name-style="western"><surname>Inaba</surname><given-names>K</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>M</given-names></name><name name-style="western"><surname>Byerly</surname><given-names>S</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Matsushima</surname><given-names>K</given-names></name><name name-style="western"><surname>Haltmeier</surname><given-names>T</given-names></name><name name-style="western"><surname>Benjamin</surname><given-names>E</given-names></name><name name-style="western"><surname>Lam</surname><given-names>L</given-names></name><name name-style="western"><surname>Demetriades</surname><given-names>D</given-names></name></person-group><article-title>The impact of pre-injury controlled substance use on clinical outcomes following trauma</article-title><source>J Trauma Acute Care Surg.</source><year>2016</year><volume>81</volume><issue>5</issue><fpage>913</fpage><pub-id pub-id-type="doi">10.1097/TA.0000000000001229</pub-id><pub-id pub-id-type="pmid">27537515</pub-id><pub-id pub-id-type="pmcid">PMC5074856</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Cheng V, Inaba K, Johnson M, Byerly S, Jiang Y, Matsushima K, Haltmeier T, Benjamin E, Lam L, Demetriades D. The impact of pre-injury controlled substance use on clinical outcomes following trauma. J Trauma Acute Care Surg. 2016;81(5):913.<pub-id pub-id-type="pmid">27537515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/TA.0000000000001229</pub-id><pub-id pub-id-type="pmcid">PMC5074856</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Anand</surname><given-names>P</given-names></name><name name-style="western"><surname>Springer</surname><given-names>SA</given-names></name><name name-style="western"><surname>Copenhaver</surname><given-names>MM</given-names></name><name name-style="western"><surname>Altice</surname><given-names>FL</given-names></name></person-group><article-title>Neurocognitive impairment and hiv risk factors: a reciprocal relationship</article-title><source>AIDS Behav.</source><year>2010</year><volume>14</volume><fpage>1213</fpage><lpage>1226</lpage><pub-id pub-id-type="doi">10.1007/s10461-010-9684-1</pub-id><pub-id pub-id-type="pmid">20232242</pub-id><pub-id pub-id-type="pmcid">PMC2906682</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Anand P, Springer SA, Copenhaver MM, Altice FL. Neurocognitive impairment and hiv risk factors: a reciprocal relationship. AIDS Behav. 2010;14:1213&#8211;26.<pub-id pub-id-type="pmid">20232242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s10461-010-9684-1</pub-id><pub-id pub-id-type="pmcid">PMC2906682</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Loftis</surname><given-names>JM</given-names></name><name name-style="western"><surname>Matthews</surname><given-names>AM</given-names></name><name name-style="western"><surname>Hauser</surname><given-names>P</given-names></name></person-group><article-title>Psychiatric and substance use disorders in individuals with hepatitis c: epidemiology and management</article-title><source>Drugs.</source><year>2006</year><volume>66</volume><fpage>155</fpage><lpage>174</lpage><pub-id pub-id-type="doi">10.2165/00003495-200666020-00003</pub-id><pub-id pub-id-type="pmid">16451091</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Loftis JM, Matthews AM, Hauser P. Psychiatric and substance use disorders in individuals with hepatitis c: epidemiology and management. Drugs. 2006;66:155&#8211;74.<pub-id pub-id-type="pmid">16451091</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003495-200666020-00003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>TM</given-names></name><name name-style="western"><surname>Daley</surname><given-names>DC</given-names></name></person-group><article-title>Integrated treatment of substance use and psychiatric disorders</article-title><source>Soc Work Public Health.</source><year>2013</year><volume>28</volume><issue>3&#8211;4</issue><fpage>388</fpage><lpage>406</lpage><pub-id pub-id-type="doi">10.1080/19371918.2013.774673</pub-id><pub-id pub-id-type="pmid">23731427</pub-id><pub-id pub-id-type="pmcid">PMC3753025</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Kelly TM, Daley DC. Integrated treatment of substance use and psychiatric disorders. Soc Work Public Health. 2013;28(3&#8211;4):388&#8211;406.<pub-id pub-id-type="pmid">23731427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/19371918.2013.774673</pub-id><pub-id pub-id-type="pmcid">PMC3753025</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gan</surname><given-names>WQ</given-names></name><name name-style="western"><surname>Buxton</surname><given-names>JA</given-names></name><name name-style="western"><surname>Scheuermeyer</surname><given-names>FX</given-names></name><name name-style="western"><surname>Palis</surname><given-names>H</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>B</given-names></name><name name-style="western"><surname>Desai</surname><given-names>R</given-names></name><name name-style="western"><surname>Janjua</surname><given-names>NZ</given-names></name><name name-style="western"><surname>Slaunwhite</surname><given-names>AK</given-names></name></person-group><article-title>Risk of cardiovascular diseases in relation to substance use disorders</article-title><source>Drug Alcohol Depend.</source><year>2021</year><volume>229</volume><fpage>109132</fpage><pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.109132</pub-id><pub-id pub-id-type="pmid">34768052</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gan WQ, Buxton JA, Scheuermeyer FX, Palis H, Zhao B, Desai R, Janjua NZ, Slaunwhite AK. Risk of cardiovascular diseases in relation to substance use disorders. Drug Alcohol Depend. 2021;229:109132.<pub-id pub-id-type="pmid">34768052</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.drugalcdep.2021.109132</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Peppin</surname><given-names>JF</given-names></name><name name-style="western"><surname>Cheatle</surname><given-names>MD</given-names></name><name name-style="western"><surname>Kirsh</surname><given-names>KL</given-names></name><name name-style="western"><surname>McCarberg</surname><given-names>BH</given-names></name></person-group><article-title>The complexity model: a novel approach to improve chronic pain care</article-title><source>Pain Med.</source><year>2015</year><volume>16</volume><issue>4</issue><fpage>653</fpage><lpage>666</lpage><pub-id pub-id-type="doi">10.1111/pme.12621</pub-id><pub-id pub-id-type="pmid">25752874</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Peppin JF, Cheatle MD, Kirsh KL, McCarberg BH. The complexity model: a novel approach to improve chronic pain care. Pain Med. 2015;16(4):653&#8211;66.<pub-id pub-id-type="pmid">25752874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/pme.12621</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schaible</surname><given-names>H-G</given-names></name></person-group><article-title>Mechanisms of chronic pain in osteoarthritis</article-title><source>Curr Rheumatol Rep.</source><year>2012</year><volume>14</volume><fpage>549</fpage><lpage>556</lpage><pub-id pub-id-type="doi">10.1007/s11926-012-0279-x</pub-id><pub-id pub-id-type="pmid">22798062</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Schaible H-G. Mechanisms of chronic pain in osteoarthritis. Curr Rheumatol Rep. 2012;14:549&#8211;56.<pub-id pub-id-type="pmid">22798062</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11926-012-0279-x</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kalaria</surname><given-names>RN</given-names></name><name name-style="western"><surname>Akinyemi</surname><given-names>R</given-names></name><name name-style="western"><surname>Ihara</surname><given-names>M</given-names></name></person-group><article-title>Stroke injury, cognitive impairment and vascular dementia</article-title><source>Biochim Biophys Acta (BBA) - Mol Basis Dis.</source><year>2016</year><volume>1862</volume><issue>5</issue><fpage>915</fpage><lpage>925</lpage><pub-id pub-id-type="doi">10.1016/j.bbadis.2016.01.015</pub-id><pub-id pub-id-type="pmcid">PMC4827373</pub-id><pub-id pub-id-type="pmid">26806700</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Kalaria RN, Akinyemi R, Ihara M. Stroke injury, cognitive impairment and vascular dementia. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2016;1862(5):915&#8211;25.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bbadis.2016.01.015</pub-id><pub-id pub-id-type="pmcid">PMC4827373</pub-id><pub-id pub-id-type="pmid">26806700</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leys</surname><given-names>D</given-names></name><name name-style="western"><surname>H&#233;non</surname><given-names>H</given-names></name><name name-style="western"><surname>Mackowiak-Cordoliani</surname><given-names>M-A</given-names></name><name name-style="western"><surname>Pasquier</surname><given-names>F</given-names></name></person-group><article-title>Poststroke dementia</article-title><source>Lancet Neurol.</source><year>2005</year><volume>4</volume><issue>11</issue><fpage>752</fpage><lpage>759</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(05)70221-0</pub-id><pub-id pub-id-type="pmid">16239182</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Leys D, H&#233;non H, Mackowiak-Cordoliani M-A, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4(11):752&#8211;9.<pub-id pub-id-type="pmid">16239182</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(05)70221-0</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Howard</surname><given-names>G</given-names></name><name name-style="western"><surname>Cushman</surname><given-names>M</given-names></name><name name-style="western"><surname>Kissela</surname><given-names>BM</given-names></name><name name-style="western"><surname>Kleindorfer</surname><given-names>DO</given-names></name><name name-style="western"><surname>McClure</surname><given-names>LA</given-names></name><name name-style="western"><surname>Safford</surname><given-names>MM</given-names></name><name name-style="western"><surname>Rhodes</surname><given-names>JD</given-names></name><name name-style="western"><surname>Soliman</surname><given-names>EZ</given-names></name><name name-style="western"><surname>Moy</surname><given-names>CS</given-names></name><name name-style="western"><surname>Judd</surname><given-names>SE</given-names></name><etal/></person-group><article-title>Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass</article-title><source>Stroke.</source><year>2011</year><volume>42</volume><issue>12</issue><fpage>3369</fpage><lpage>3375</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.625277</pub-id><pub-id pub-id-type="pmid">21960581</pub-id><pub-id pub-id-type="pmcid">PMC3226886</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Howard G, Cushman M, Kissela BM, Kleindorfer DO, McClure LA, Safford MM, Rhodes JD, Soliman EZ, Moy CS, Judd SE, et al. Traditional risk factors as the underlying cause of racial disparities in stroke: lessons from the half-full (empty?) glass. Stroke. 2011;42(12):3369&#8211;75.<pub-id pub-id-type="pmid">21960581</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.111.625277</pub-id><pub-id pub-id-type="pmcid">PMC3226886</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wadi</surname><given-names>NM</given-names></name><name name-style="western"><surname>Asantewa-Ampaduh</surname><given-names>S</given-names></name><name name-style="western"><surname>Rivas</surname><given-names>C</given-names></name><name name-style="western"><surname>Goff</surname><given-names>LM</given-names></name></person-group><article-title>Culturally tailored lifestyle interventions for the prevention and management of type 2 diabetes in adults of black african ancestry: a systematic review of tailoring methods and their effectiveness</article-title><source>Public Health Nutr.</source><year>2022</year><volume>25</volume><issue>2</issue><fpage>422</fpage><lpage>436</lpage><pub-id pub-id-type="pmid">34435943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1368980021003682</pub-id><pub-id pub-id-type="pmcid">PMC8883766</pub-id></element-citation><mixed-citation id="mc-CR43" publication-type="journal">Wadi NM, Asantewa-Ampaduh S, Rivas C, Goff LM. Culturally tailored lifestyle interventions for the prevention and management of type 2 diabetes in adults of black african ancestry: a systematic review of tailoring methods and their effectiveness. Public Health Nutr. 2022;25(2):422&#8211;36.<pub-id pub-id-type="pmid">34435943</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1017/S1368980021003682</pub-id><pub-id pub-id-type="pmcid">PMC8883766</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Rees</surname><given-names>DC</given-names></name><name name-style="western"><surname>Williams</surname><given-names>TN</given-names></name><name name-style="western"><surname>Gladwin</surname><given-names>MT</given-names></name></person-group><article-title>Sickle-cell disease</article-title><source>Lancet.</source><year>2010</year><volume>376</volume><issue>9757</issue><fpage>2018</fpage><lpage>2031</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61029-X</pub-id><pub-id pub-id-type="pmid">21131035</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018&#8211;31.<pub-id pub-id-type="pmid">21131035</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(10)61029-X</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Platt</surname><given-names>OS</given-names></name></person-group><article-title>Prevention and management of stroke in sickle cell anemia</article-title><source>ASH Educ Program Book.</source><year>2006</year><volume>2006</volume><issue>1</issue><fpage>54</fpage><lpage>57</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/asheducation-2006.1.54</pub-id><pub-id pub-id-type="pmid">17124040</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Platt OS. Prevention and management of stroke in sickle cell anemia. ASH Educ Program Book. 2006;2006(1):54&#8211;7.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/asheducation-2006.1.54</pub-id><pub-id pub-id-type="pmid">17124040</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="other">Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW, Wethers DL, Pegelow CH, Gill FM, and&#160;the&#160;Cooperative&#160;Study&#160;of&#160;Sickle&#160;Cell&#160;Disease. Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood J Am Soc Hematol. 1998;91(1):288&#8211;294.<pub-id pub-id-type="pmid">9414296</pub-id></mixed-citation></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Feigin</surname><given-names>VL</given-names></name><name name-style="western"><surname>Norrving</surname><given-names>B</given-names></name><name name-style="western"><surname>Mensah</surname><given-names>GA</given-names></name></person-group><article-title>Global burden of stroke</article-title><source>Circ Res.</source><year>2017</year><volume>120</volume><issue>3</issue><fpage>439</fpage><lpage>448</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.116.308413</pub-id><pub-id pub-id-type="pmid">28154096</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Feigin VL, Norrving B, Mensah GA. Global burden of stroke. Circ Res. 2017;120(3):439&#8211;48.<pub-id pub-id-type="pmid">28154096</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.116.308413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kittner</surname><given-names>SJ</given-names></name><name name-style="western"><surname>White</surname><given-names>LR</given-names></name><name name-style="western"><surname>Losonczy</surname><given-names>KG</given-names></name><name name-style="western"><surname>Wolf</surname><given-names>PA</given-names></name><name name-style="western"><surname>Hebel</surname><given-names>JR</given-names></name></person-group><article-title>Black-white differences in stroke incidence in a national sample: the contribution of hypertension and diabetes mellitus</article-title><source>Jama.</source><year>1990</year><volume>264</volume><issue>10</issue><fpage>1267</fpage><lpage>1270</lpage><pub-id pub-id-type="doi">10.1001/jama.1990.03450100057025</pub-id><pub-id pub-id-type="pmid">2388378</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Kittner SJ, White LR, Losonczy KG, Wolf PA, Hebel JR. Black-white differences in stroke incidence in a national sample: the contribution of hypertension and diabetes mellitus. Jama. 1990;264(10):1267&#8211;70.<pub-id pub-id-type="pmid">2388378</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><mixed-citation publication-type="other">Delord M, Ashworth M, Douiri A. Does ethnicity alter the risk of stroke in patients with modifiable cardiometabolic risk factors? medRxiv. 2024;2024.04.08.24305017 [Preprint]. 10.1101/2024.04.08.24305017.</mixed-citation></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Glynn</surname><given-names>LG</given-names></name><name name-style="western"><surname>Valderas</surname><given-names>JM</given-names></name><name name-style="western"><surname>Healy</surname><given-names>P</given-names></name><name name-style="western"><surname>Burke</surname><given-names>E</given-names></name><name name-style="western"><surname>Newell</surname><given-names>J</given-names></name><name name-style="western"><surname>Gillespie</surname><given-names>P</given-names></name><name name-style="western"><surname>Murphy</surname><given-names>AW</given-names></name></person-group><article-title>The prevalence of multimorbidity in primary care and its effect on health care utilization and cost</article-title><source>Fam Pract.</source><year>2011</year><volume>28</volume><issue>5</issue><fpage>516</fpage><lpage>523</lpage><pub-id pub-id-type="doi">10.1093/fampra/cmr013</pub-id><pub-id pub-id-type="pmid">21436204</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Glynn LG, Valderas JM, Healy P, Burke E, Newell J, Gillespie P, Murphy AW. The prevalence of multimorbidity in primary care and its effect on health care utilization and cost. Fam Pract. 2011;28(5):516&#8211;23.<pub-id pub-id-type="pmid">21436204</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/fampra/cmr013</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>J-Y</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y-H</given-names></name><name name-style="western"><surname>Tong</surname><given-names>J</given-names></name><name name-style="western"><surname>Qin</surname><given-names>L-Q</given-names></name></person-group><article-title>Depression and risk of stroke: a meta-analysis of prospective studies</article-title><source>Stroke.</source><year>2012</year><volume>43</volume><issue>1</issue><fpage>32</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.111.630871</pub-id><pub-id pub-id-type="pmid">22020036</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Dong J-Y, Zhang Y-H, Tong J, Qin L-Q. Depression and risk of stroke: a meta-analysis of prospective studies. Stroke. 2012;43(1):32&#8211;7.<pub-id pub-id-type="pmid">22020036</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.111.630871</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Everson-Rose</surname><given-names>SA</given-names></name><name name-style="western"><surname>Roetker</surname><given-names>NS</given-names></name><name name-style="western"><surname>Lutsey</surname><given-names>PL</given-names></name><name name-style="western"><surname>Kershaw</surname><given-names>KN</given-names></name><name name-style="western"><surname>Longstreth</surname><given-names>WT</given-names><suffix>Jr</suffix></name><name name-style="western"><surname>Sacco</surname><given-names>RL</given-names></name><name name-style="western"><surname>Diez Roux</surname><given-names>AV</given-names></name><name name-style="western"><surname>Alonso</surname><given-names>A</given-names></name></person-group><article-title>Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis</article-title><source>Stroke.</source><year>2014</year><volume>45</volume><issue>8</issue><fpage>2318</fpage><lpage>2323</lpage><pub-id pub-id-type="doi">10.1161/STROKEAHA.114.004815</pub-id><pub-id pub-id-type="pmid">25013018</pub-id><pub-id pub-id-type="pmcid">PMC4131200</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Everson-Rose SA, Roetker NS, Lutsey PL, Kershaw KN, Longstreth WT Jr, Sacco RL, Diez Roux AV, Alonso A. Chronic stress, depressive symptoms, anger, hostility, and risk of stroke and transient ischemic attack in the multi-ethnic study of atherosclerosis. Stroke. 2014;45(8):2318&#8211;23.<pub-id pub-id-type="pmid">25013018</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/STROKEAHA.114.004815</pub-id><pub-id pub-id-type="pmcid">PMC4131200</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Georgiev</surname><given-names>T</given-names></name><name name-style="western"><surname>Angelov</surname><given-names>AK</given-names></name></person-group><article-title>Modifiable risk factors in knee osteoarthritis: treatment implications</article-title><source>Rheumatol Int.</source><year>2019</year><volume>39</volume><issue>7</issue><fpage>1145</fpage><lpage>1157</lpage><pub-id pub-id-type="doi">10.1007/s00296-019-04290-z</pub-id><pub-id pub-id-type="pmid">30911813</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Georgiev T, Angelov AK. Modifiable risk factors in knee osteoarthritis: treatment implications. Rheumatol Int. 2019;39(7):1145&#8211;57.<pub-id pub-id-type="pmid">30911813</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00296-019-04290-z</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Corlateanu</surname><given-names>A</given-names></name><name name-style="western"><surname>Stratan</surname><given-names>I</given-names></name><name name-style="western"><surname>Covantev</surname><given-names>S</given-names></name><name name-style="western"><surname>Botnaru</surname><given-names>V</given-names></name><name name-style="western"><surname>Corlateanu</surname><given-names>O</given-names></name><name name-style="western"><surname>Siafakas</surname><given-names>N</given-names></name></person-group><article-title>Asthma and stroke: a narrative review</article-title><source>Asthma Res Pract.</source><year>2021</year><volume>7</volume><issue>1</issue><fpage>1</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1186/s40733-021-00069-x</pub-id><pub-id pub-id-type="pmid">33608061</pub-id><pub-id pub-id-type="pmcid">PMC7896413</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Corlateanu A, Stratan I, Covantev S, Botnaru V, Corlateanu O, Siafakas N. Asthma and stroke: a narrative review. Asthma Res Pract. 2021;7(1):1&#8211;17.<pub-id pub-id-type="pmid">33608061</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s40733-021-00069-x</pub-id><pub-id pub-id-type="pmcid">PMC7896413</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van&#160;Rooy</surname><given-names>M-J</given-names></name><name name-style="western"><surname>Pretorius</surname><given-names>E1</given-names></name></person-group><article-title>Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events</article-title><source>Curr Med Chem.</source><year>2014</year><volume>21</volume><issue>19</issue><fpage>2121</fpage><lpage>2129</lpage><pub-id pub-id-type="doi">10.2174/0929867321666131227162950</pub-id><pub-id pub-id-type="pmid">24372218</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">van&#160;Rooy M-J, Pretorius E1. Obesity, hypertension and hypercholesterolemia as risk factors for atherosclerosis leading to ischemic events. Curr Med Chem. 2014;21(19):2121&#8211;9.<pub-id pub-id-type="pmid">24372218</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2174/0929867321666131227162950</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Atiquzzaman</surname><given-names>M</given-names></name><name name-style="western"><surname>Karim</surname><given-names>ME</given-names></name><name name-style="western"><surname>Kopec</surname><given-names>J</given-names></name><name name-style="western"><surname>Wong</surname><given-names>H</given-names></name><name name-style="western"><surname>Anis</surname><given-names>AH</given-names></name></person-group><article-title>Role of nonsteroidal antiinflammatory drugs in the association between osteoarthritis and cardiovascular diseases: a longitudinal study</article-title><source>Arthritis Rheumatol.</source><year>2019</year><volume>71</volume><issue>11</issue><fpage>1835</fpage><lpage>1843</lpage><pub-id pub-id-type="doi">10.1002/art.41027</pub-id><pub-id pub-id-type="pmid">31389178</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Atiquzzaman M, Karim ME, Kopec J, Wong H, Anis AH. Role of nonsteroidal antiinflammatory drugs in the association between osteoarthritis and cardiovascular diseases: a longitudinal study. Arthritis Rheumatol. 2019;71(11):1835&#8211;43.<pub-id pub-id-type="pmid">31389178</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/art.41027</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><mixed-citation publication-type="other">Appleton SL, Ruffin RE, Wilson DH, Taylor AW, Adams RJ, North&#160;West&#160;Adelaide&#160;Cohort&#160;Health&#160;Study&#160;Team, et&#160;al. Cardiovascular disease risk associated with asthma and respiratory morbidity might be mediated by short-acting <inline-graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="12875_2024_2636_Article_IEq3.gif"/>2-agonists. J Allergy Clin Immunol. 2009;123(1):124&#8211;130.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaci.2008.10.032</pub-id><pub-id pub-id-type="pmid">19130933</pub-id></mixed-citation></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeiger</surname><given-names>R</given-names></name><name name-style="western"><surname>Sullivan</surname><given-names>P</given-names></name><name name-style="western"><surname>Chung</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kreindler</surname><given-names>JL</given-names></name><name name-style="western"><surname>Zimmerman</surname><given-names>NM</given-names></name><name name-style="western"><surname>Tkacz</surname><given-names>J</given-names></name></person-group><article-title>Systemic corticosteroid-related complications and costs in adults with persistent asthma</article-title><source>J Allergy Clin Immunol Pract.</source><year>2020</year><volume>8</volume><issue>10</issue><fpage>3455</fpage><lpage>3465</lpage><pub-id pub-id-type="doi">10.1016/j.jaip.2020.06.055</pub-id><pub-id pub-id-type="pmid">32679349</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Zeiger R, Sullivan P, Chung Y, Kreindler JL, Zimmerman NM, Tkacz J. Systemic corticosteroid-related complications and costs in adults with persistent asthma. J Allergy Clin Immunol Pract. 2020;8(10):3455&#8211;65.<pub-id pub-id-type="pmid">32679349</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jaip.2020.06.055</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cazzola</surname><given-names>M</given-names></name><name name-style="western"><surname>Rogliani</surname><given-names>P</given-names></name><name name-style="western"><surname>Calzetta</surname><given-names>L</given-names></name><name name-style="western"><surname>Matera</surname><given-names>MG</given-names></name></person-group><article-title>Bronchodilators in subjects with asthma-related comorbidities</article-title><source>Respir Med.</source><year>2019</year><volume>151</volume><fpage>43</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1016/j.rmed.2019.04.001</pub-id><pub-id pub-id-type="pmid">31047116</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Cazzola M, Rogliani P, Calzetta L, Matera MG. Bronchodilators in subjects with asthma-related comorbidities. Respir Med. 2019;151:43&#8211;8.<pub-id pub-id-type="pmid">31047116</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.rmed.2019.04.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Menaa</surname><given-names>F</given-names></name></person-group><article-title>Stroke in sickle cell anemia patients: a need for multidisciplinary approaches</article-title><source>Atherosclerosis.</source><year>2013</year><volume>229</volume><issue>2</issue><fpage>496</fpage><lpage>503</lpage><pub-id pub-id-type="doi">10.1016/j.atherosclerosis.2013.05.006</pub-id><pub-id pub-id-type="pmid">23746538</pub-id></element-citation><mixed-citation id="mc-CR60" publication-type="journal">Menaa F. Stroke in sickle cell anemia patients: a need for multidisciplinary approaches. Atherosclerosis. 2013;229(2):496&#8211;503.<pub-id pub-id-type="pmid">23746538</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.atherosclerosis.2013.05.006</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Barnett</surname><given-names>K</given-names></name><name name-style="western"><surname>Mercer</surname><given-names>SW</given-names></name><name name-style="western"><surname>Norbury</surname><given-names>M</given-names></name><name name-style="western"><surname>Watt</surname><given-names>G</given-names></name><name name-style="western"><surname>Wyke</surname><given-names>S</given-names></name><name name-style="western"><surname>Guthrie</surname><given-names>B</given-names></name></person-group><article-title>Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study</article-title><source>Lancet.</source><year>2012</year><volume>380</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(12)60240-2</pub-id><pub-id pub-id-type="pmid">22579043</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie B. Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. 2012;380:37&#8211;43.<pub-id pub-id-type="pmid">22579043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(12)60240-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hart</surname><given-names>RG</given-names></name><name name-style="western"><surname>Diener</surname><given-names>H-C</given-names></name><name name-style="western"><surname>Coutts</surname><given-names>SB</given-names></name><name name-style="western"><surname>Easton</surname><given-names>JD</given-names></name><name name-style="western"><surname>Granger</surname><given-names>CB</given-names></name><name name-style="western"><surname>O&#8217;Donnell</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Sacco</surname><given-names>RL</given-names></name><name name-style="western"><surname>Connolly</surname><given-names>SJ</given-names></name></person-group><article-title>Embolic strokes of undetermined source: the case for a new clinical construct</article-title><source>Lancet Neurol.</source><year>2014</year><volume>13</volume><issue>4</issue><fpage>429</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/S1474-4422(13)70310-7</pub-id><pub-id pub-id-type="pmid">24646875</pub-id></element-citation><mixed-citation id="mc-CR62" publication-type="journal">Hart RG, Diener H-C, Coutts SB, Easton JD, Granger CB, O&#8217;Donnell MJ, Sacco RL, Connolly SJ. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014;13(4):429&#8211;38.<pub-id pub-id-type="pmid">24646875</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S1474-4422(13)70310-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lang</surname><given-names>S-J</given-names></name><name name-style="western"><surname>Abel</surname><given-names>GA</given-names></name><name name-style="western"><surname>Mant</surname><given-names>J</given-names></name><name name-style="western"><surname>Mullis</surname><given-names>R</given-names></name></person-group><article-title>Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study</article-title><source>BMJ Open.</source><year>2016</year><volume>6</volume><issue>3</issue><fpage>e009984</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2015-009984</pub-id><pub-id pub-id-type="pmid">27000783</pub-id><pub-id pub-id-type="pmcid">PMC4809080</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Lang S-J, Abel GA, Mant J, Mullis R. Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. BMJ Open. 2016;6(3):e009984.<pub-id pub-id-type="pmid">27000783</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmjopen-2015-009984</pub-id><pub-id pub-id-type="pmcid">PMC4809080</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><mixed-citation publication-type="other">Wallace E, Salisbury C, Guthrie B, Lewis C, Fahey T, Smith SM. Managing patients with multimorbidity in primary care. BMJ. 2015;350.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.h176</pub-id><pub-id pub-id-type="pmid">25646760</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>